bapr v28 i2 BUMC Merge - Baylorhealth.edu Proceedings... · 267 the logistic European System for...

266266

2014 publications of the Baylor Health Care Systemmedical and scientific staff

ANESTHESIOLOGY AND PAIN MANAGEMENT 1. Kelley SD, Ramsay MA. Respiratory rate monitoring: characterizing

performance for emerging technologies. Anesth Analg 2014;119(6):1246–1248.

2. Kudenchuk PJ, Brown SP, Daya M, Morrison LJ, Grunau BE, Rea T, Aufderheide T, Powell J, Leroux B, Vaillancourt C, Larsen J, Wittwer L, Colella MR, Stephens SW, Gamber M, Egan D, Dorian P; Resuscitation Outcomes Consortium Investigators. Resuscitation Outcomes Consor-tium-Amiodarone, Lidocaine or Placebo Study (ROC-ALPS): Rationale and methodology behind an out-of-hospital cardiac arrest antiarrhythmic drug trial. Am Heart J 2014;167(5):653–659.e4.

3. Ramsay M. Breathing is good. J Clin Monit Comput 2014 Jul 26 [Epub ahead of print].

4. Ramsay M. Listening to breathing again! J Clin Monit Comput 2014;28(6):559–560.

5. Ramsay M. Th e biological cost of the depression of consciousness. Revista Colombiana de Anestesiologia 2014 Dec 13 [Epub ahead of print].

6. Ramsay MAE, Newman KB, Jacobson RM, Richardson CT, Rogers L, Brown BJ, Hein HAT, De Vol EB, Daoud YA. Sedation levels during propofol administration for outpatient colonoscopies. Proc (Bayl Univ Med Cent) 2014;27(1):12–15.

7. Ramsay MAE, Newman KB, Leeper B, Hamman BL, Hebeler RF Jr., Henry AC, Kourlis H Jr., Wood RE, Stecher JA, Hein HAT. Dexmedetomidine infusion for analgesia up to 48 hours after lung surgery performed by lateral thoracotomy. Proc (Bayl Univ Med Cent) 2014;27(1):3–10.

8. Stiell IG, Brown SP, Nichol G, Cheskes S, Vaillancourt C, Callaway CW, Morrison LJ, Christenson J, Aufderheide TP, Davis DP, Free C, Hostler D, Stouff er JA, Idris AH; Resuscitation Outcomes Consortium Investigators. What is the optimal chest compression depth during out-of-hospital cardiac arrest resuscitation of adult patients? Circulation 2014;130(22):1962–1970.

CARDIOLOGY/CARDIAC, VASCULAR, AND THORACIC SURGERY9. Acker MA, Parides MK, Perrault LP, Moskowitz AJ, Gelijns

AC, Voisine P, Smith PK, Hung JW, Blackstone EH, Puskas JD, Argenziano M, Gammie JS, Mack M, Ascheim DD, Bagiella E, Moquete EG, Ferguson TB, Horvath KA, Geller NL, Miller MA, Woo YJ, D’Alessandro DA, Ailawadi G, Dagenais F, Gardner TJ, O’Gara PT, Michler RE, Kron IL; CTSN. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med 2014;370(1):23–32.

10. Adams J, Cheng D, Lee J, Shock T, Kennedy K, Pate S. Use of the boot-strap method to develop a physical fi tness test for public safety offi cers who serve as both police offi cers and fi refi ghters. Proc (Bayl Univ Med Cent) 2014;27(3):199–202.

11. Adams J, DeJong S, Arnett JK, Kennedy K, Franklin JO, Berbarie RF. High-intensity cardiac rehabilitation training of a fi refi ghter after place-ment of an implantable cardioverter-defi brillator. Proc (Bayl Univ Med Cent) 2014;27(3):226–228.

12. Adams J, Schmid J, Parker RD, Coast JR, Cheng D, Killian AD, McCray S, Strauss D, McLeroy Dejong S, Berbarie R. Comparison of force exerted on the sternum during a sneeze versus during low-, moderate-, and high-intensity bench press resistance exercise with and

without the Valsalva maneuver in healthy volunteers. Am J Cardiol 2014;113(6):1045–1048.

13. Afi lalo J, Alexander KP, Mack MJ, Maurer MS, Green P, Allen LA, Popma JJ, Ferrucci L, Forman DE. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol 2014;63(8):747–762.

14. Arnold SV, Lei Y, Reynolds MR, Magnuson EA, Suri RM, Tuzcu EM, Petersen JL 2nd, Douglas PS, Svensson LG, Gada H, Th ourani VH, Kodali SK, Mack MJ, Leon MB, Cohen DJ; PARTNER Investigators. Costs of periprocedural complications in patients treated with trans-catheter aortic valve replacement: results from the placement of aortic transcatheter valve trial. Circ Cardiovasc Interv 2014;7(6):829–836.

15. Arnold SV, Reynolds MR, Lei Y, Magnuson EA, Kirtane AJ, Kodali SK, Zajarias A, Th ourani VH, Green P, Rodés-Cabau J, Beohar N, Mack MJ, Leon MB, Cohen DJ; PARTNER Investigators. Predictors of poor outcomes after transcatheter aortic valve replacement: results from the PARTNER (Placement of Aortic Transcatheter Valve) trial. Circulation 2014;129(25):2682–2690.

16. Ascheim DD, Gelijns AC, Goldstein D, Moye LA, Smedira N, Lee S, Klodell CT, Szady A, Parides MK, Jeff ries NO, Skerrett D, Taylor DA, Rame JE, Milano C, Rogers JG, Lynch J, Dewey T, Eichhorn E, Sun B, Feldman D, Simari R, O’Gara PT, Taddei-Peters WC, Miller MA, Naka Y, Bagiella E, Rose EA, Woo YJ. Mesenchymal precursor cells as adjunc-tive therapy in recipients of contemporary left ventricular assist devices. Circulation 2014;129(22):2287–2296.

17. Ball T, McCullough PA. Statins for the prevention of contrast-induced acute kidney injury. Nephron Clin Pract 2014;127(1–4):165–171.

18. Ball T, Wheelan K, McCullough PA. Chronic anticoagulation in chronic kidney disease. J Am Coll Cardiol 2014;64(23):2483–2485.

19. Bax JJ, Delgado V, Bapat V, Baumgartner H, Collet JP, Erbel R, Hamm C, Kappetein AP, Leipsic J, Leon MB, MacCarthy P, Piazza N, Pibarot P, Roberts WC, Rodés-Cabau J, Serruys PW, Th omas M, Vahanian A, Webb J, Zamorano JL, Windecker S. Open issues in transcatheter aortic valve implantation. Part 2: procedural issues and outcomes after transcatheter aortic valve implantation. Eur Heart J 2014;35(38):2639–2654.

20. Bax JJ, Delgado V, Bapat V, Baumgartner H, Collet JP, Erbel R, Hamm C, Kappetein AP, Leipsic J, Leon MB, MacCarthy P, Piazza N, Pibarot P, Roberts WC, Rodés-Cabau J, Serruys PW, Th omas M, Vahanian A, Webb J, Zamorano JL, Windecker S. Open issues in transcatheter aortic valve implantation. Part 1: patient selection and treatment strategy for trans-catheter aortic valve implantation. Eur Heart J 2014;35(38):2627–2638.

21. Benjamin MM, Fazel P, Filardo G, Choi JW, Stoler RC. Prevalence of and risk factors of renal artery stenosis in patients with resistant hypertension. Am J Cardiol 2014;113(4):687–690.

22. Benjamin MM, McMaster KS, Stoler RC, Schussler JM. Th irty-day safety and effi cacy of prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for non-urgent indications and an-ticoagulated with bivalirudin. IJC Metabolic & Endocrine 2014;2:26–29.

23. Benjamin MM, Smith RL, Grayburn PA. Ischemic and functional mitral regurgitation in heart failure: natural history and treatment. Curr Cardiol Rep 2014;16(8):517.

24. Beohar N, Whisenant B, Kirtane AJ, Leon MB, Tuzcu EM, Makkar R, Svensson LG, Miller DC, Smith CR, Pichard AD, Herrmann HC, Th ourani VH, Szeto WY, Lim S, Fischbein M, Fearon WF, O’Neill W, Xu K, Dewey T, Mack M. Th e relative performance characteristics of

Proc (Bayl Univ Med Cent) 2015;28(2):266–285

267

the logistic European System for Cardiac Operative Risk Evaluation score and the Society of Th oracic Surgeons score in the Placement of Aortic Transcatheter Valves trial. J Th orac Cardiovasc Surg 2014;148(6):2830–2837.e1.

25. Beohar N, Zajarias A, Th ourani VH, Herrmann HC, Mack M, Kapadia S, Green P, Arnold SV, Cohen DJ, Généreux P, Xu K, Leon MB, Kirtane AJ. Analysis of early out-of hospital mortality after trans-catheter aortic valve implantation among patients with aortic ste-nosis successfully discharged from the hospital and alive at 30 days (from the placement of aortic transcatheter valves trial). Am J Cardiol 2014;114(10):1550–1555.

26. Brennan JM, Holmes DR, Sherwood MW, Edwards FH, Carroll JD, Grover FL, Tuzcu EM, Th ourani V, Brindis RG, Shahian DM, Svensson LG, O’Brien SM, Shewan CM, Hewitt K, Gammie JS, Rumsfeld JS, Peterson ED, Mack MJ. Th e association of transcatheter aortic valve replacement availability and hospital aortic valve replacement volume and mortality in the United States. Ann Th orac Surg 2014;98(6):2016–2022.

27. Brinkman W, Herbert MA, O’Brien S, Filardo G, Prince S, Dewey T, Magee M, Ryan W, Mack M. Preoperative beta-blocker use in coronary artery bypass grafting surgery: national database analysis. JAMA Intern Med 2014;174(8):1320–1327.

28. Chawla LS, Herzog CA, Costanzo MR, Tumlin J, Kellum JA, McCullough PA, Ronco C; ADQI XI Workgroup. Proposal for a functional classifi -cation system of heart failure in patients with end-stage renal disease: proceedings of the acute dialysis quality initiative (ADQI) XI workgroup. J Am Coll Cardiol 2014;63(13):1246–1252.

29. Chen S, Bastarrachea RA, Roberts BJ, Voruganti VS, Frost PA, Nava- Gonzalez EJ, Arriaga-Cazares HE, Chen J, Huang P, DeFronzo RA, Comuzzie AG, Grayburn PA. Successful beta cells islet regeneration in streptozotocin-induced diabetic baboons using ultrasound-targeted microbubble gene therapy with cyclinD2/CDK4/GLP1. Cell Cycle 2014;13(7):1145–1151.

30. Chin MP, Reisman SA, Bakris GL, O’Grady M, Linde PG, McCullough PA, Packham D, Vaziri ND, Ward KW, Warnock DG, Meyer CJ. Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl. Am J Nephrol 2014;39(6):499–508.

31. Chin MP, Wrolstad D, Bakris GL, Chertow GM, de Zeeuw D, Goldsberry A, Linde PG, McCullough PA, McMurray JJ, Wittes J, Meyer CJ. Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl. J Card Fail 2014;20(12):953–958.

32. Divakaran V, Caldera A, Stephens J, Gonzalez R. Pulmonary artery catheter entrapment in cardiac surgery: a simple percutaneous solution. Cardiovasc Interv Th er 2014 Dec 30 [Epub ahead of print].

33. Donaldson EE, Ko JM, Gonzalez-Stawinski G, Hall SA, Roberts WC. Secondary arrhythmogenic right ventricular cardiomyopathy decades after operative repair of tetralogy of Fallot. Am J Cardiol 2014;114(5):806–809.

34. Donaldson EE, Ko JM, Kuiper JJ, Chamogeorgakis T, Roberts WC. Fat in the ventricular septum. Proc (Bayl Univ Med Cent) 2014;27(3):231–232.

35. Fearon WF1, Kodali S2, Doshi D2, Fischbein MP3, Yeung AC3, Tuzcu EM4, Rihal CS5, Babaliaros V6, Zajarias A7, Herrmann HC8, Brown DL9, Mack M10, Teirstein PS11, Whisenant BK12, Makkar R13, Kapadia S4, Leon MB3; PARTNER Trial Investigators. Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (nonrandomized continued access) registry. JACC Cardiovasc Interv 2014;7(11):1245–1251.

36. Filardo G, Lederle FA, Ballard DJ, Hamilton C, da Graca B, Herrin J, Sass DM, Johnson GR, Powell JT. Eff ect of age on survival between open repair and surveillance for small abdominal aortic aneurysms. Am J Cardiol 2014;114(8):1281–1286.

37. Généreux P, Cohen DJ, Mack M, Rodes-Cabau J, Yadav M, Xu K, Parvataneni R, Hahn R, Kodali SK, Webb JG, Leon MB. Incidence,

predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement. J Am Coll Cardiol 2014;64(24):2605–2615.

38. Glower DD, Kar S, Trento A, Lim DS, Bajwa T, Quesada R, Whitlow PL, Rinaldi MJ, Grayburn P, Mack MJ, Mauri L, McCarthy PM, Feldman T. Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study. J Am Coll Cardiol 2014;64(2):172–181.

39. Gopalakrishnan D, Gopal A, Grayburn PA. Evaluating paravalvular leak after TAVR. Heart 2014;100(24):1903–1904.

40. Grayburn PA, Carabello B, Hung J, Gillam LD, Liang D, Mack MJ, McCarthy PM, Miller DC, Trento A, Siegel RJ. Defi ning “severe” second-ary mitral regurgitation: emphasizing an integrated approach. J Am Coll Cardiol 2014;64(25):2792–2801.

41. Grayburn PA, Smith RL 2nd. Left ventricular ejection fraction in mitral regurgitation because of fl ail leafl et. Circ Cardiovasc Imaging 2014;7(2):220–221.

42. Hamman BL, Stout LY, Th eologes TT, Sass DM, da Graca B, Filardo G. Relation between topical application of platelet-rich plasma and vancomycin and severe deep sternal wound infections after a fi rst median sternotomy. Am J Cardiol 2014;113(8):1415–1419.

43. Harskamp RE, Alexander JH, Schulte PJ, Brophy CM, Mack MJ, Peterson ED, Williams JB, Gibson CM, Califf RM, Kouchoukos NT, Harrington RA, Ferguson TB Jr, Lopes RD. Vein graft preservation solu-tions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trial. JAMA Surg 2014;149(8):798–805.

44. Harskamp RE, Alexander JH, Schulte PJ, Jones WS, Williams JB, Mack MJ, Peterson ED, Gibson CM, Califf RM, Kouchoukos NT, Ferguson TB, de Winter RJ, Lopes RD. Impact of extracardiac vascular disease on vein graft failure and outcomes after coronary artery bypass surgery. Ann Th orac Surg 2014;97(3):824–830.

45. Head SJ, Davierwala PM, Serruys PW, Redwood SR, Colombo A, Mack MJ, Morice MC, Holmes DR Jr, Feldman TE, Ståhle E, Underwood P, Dawkins KD, Kappetein AP, Mohr FW. Coronary artery bypass graft-ing vs. percutaneous coronary intervention for patients with three- vessel disease: fi nal fi ve-year follow-up of the SYNTAX trial. Eur Heart J 2014;35(40):2821–2830.

46. Head SJ, Parasca CA, Mack MJ, Mohr FW, Morice MC, Holmes DR Jr, Feldman TE, Dawkins KD, Colombo A, Serruys PW, Kappetein AP; for the SYNTAX Investigators. Diff erences in baseline characteristics, practice patterns and clinical outcomes in contemporary coronary artery bypass grafting in the United States and Europe: insights from the SYNTAX randomized trial and registry. Eur J Cardiothorac Surg 2014 May 12 [Epub ahead of print].

47. Henry TD, Traverse JH, Hammon BL, East CA, Bruckner B, Remmers AE, Recker D, Bull DA, Patel AN. Safety and effi cacy of ixmyelocel-T: an expanded, autologous multi-cellular therapy, in dilated cardiomyopathy. Circ Res 2014;115(8):730–737.

48. Hess CN, Lopes RD, Gibson CM, Hager R, Wojdyla DM, Englum BR, Mack MJ, Califf RM, Kouchoukos NT, Peterson ED, Alexander JH. Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV. Circulation 2014;130(17):1445–1451.

49. Holmes D, Mack M. Th e GARY Registry: a new paradigm of outcomes assessment. Eur J Cardiothorac Surg 2014;46(5):816–817.

50. Holmes DR Jr, Lakkireddy DR, Whitlock RP, Waksman R, Mack MJ. Left atrial appendage occlusion: opportunities and challenges. J Am Coll Cardiol 2014;63(4):291–298.

51. Hundae A, Afzal A, Assar MD, Schussler JM. Syncope secondary to second-degree atrioventricular block with donepezil use. Proc (Bayl Univ Med Cent) 2014;27(4):325–326.

52. Hundae A, McCullough PA. Cardiac and renal fi brosis in chronic cardio-renal syndromes. Nephron Clin Pract 2014;127(1–4):106–112.

53. Kane K, Fisher T, Bennett M, Shutze W Jr, Hicks T, Grimsley B, Gable D, Pearl G, Smith B, Shutze W Sr. Th e incidence and outcome of endothermal heat-induced thrombosis after endovenous laser ablation. Ann Vasc Surg 2014;28(7):1744–1750.

2672014 publications of the Baylor Health Care System medical and scientifi c staffApril 2015

268268

54. Keshavamurthy S, Shafi i AE, Soltesz E. Spectroscopic limb monitoring in peripheral extracorporeal membrane oxygenation. Asian Cardiovasc Th orac Ann 2014 Jun 6 [Epub ahead of print].

55. Kim RJ, McGehee E, Mack MJ. Left main occlusion secondary to aortic root rupture following transcatheter aortic valve replacement managed by left main stenting. Catheter Cardiovasc Interv 2014;83(1):E146–E149.

56. Kimmelstiel CD, Cannon L, Jobe RL, Stoler R, Pow T, Ganim R, Kayser R, Allocco DJ, Dawkins KD. TCT-578 Two-year “real-world” outcomes following implantation of the ION™ paclitaxel-eluting platinum chro-mium coronary stent in routine clinical practice: results from the ION U.S. post-approval registry. J Am Coll Cardiol 2014;64(11 S):B168.

57. Kron IL, Hung J, Overbey JR, Bouchard D, Gelijns AC, Moskowitz AJ, Voisine P, O’Gara PT, Argenziano M, Michler RE, Gillinov M, Puskas JD, Gammie JS, Mack MJ, Smith PK, Sai-Sudhakar C, Gardner TJ, Ailawadi G, Zeng X, O’Sullivan K, Parides MK, Swayze R, Th ourani V, Rose EA, Perrault LP, Acker MA; for the CTSN Investigators. Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation. J Th orac Cardiovasc Sur 2014 Nov 6 [Epub ahead of print].

58. LaPar DJ, Filardo G, Crosby IK, Speir AM, Rich JB, Kron IL, Ailawadi G. Th e challenge of achieving 1% operative mortality for coronary artery bypass grafting: a multi-institution Society of Th oracic Surgeons Database analysis. J Th orac Cardiovasc Surg 2014;148(6):2686–2696.

59. Levitsky S, Chitwood WR, Orringer MB, Mack MJ. Education above and beyond: innovative STS educational initiatives. Ann Th orac Surg 2014;97(1 Suppl):S29–S33.

60. Lim DS, Reynolds MR, Feldman T, Kar S, Herrmann HC, Wang A, Whitlow PL, Gray WA, Grayburn P, Mack MJ, Glower DD. Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair. J Am Coll Cardiol 2014;64(2):182–192.

61. Lima B, Mack M, Gonzalez-Stawinski GV. Ventricular assist devices: Th e future is now. Trends Cardiovasc Med 2014 Nov 20 [Epub ahead of print].

62. Mack M, Gopal A. Epidemiology, traditional and novel risk factors in coronary artery disease. Cardiol Clin 2014;32(3):323–332.

63. Malaisrie SC, Barnhart GR, Farivar RS, Mehall J, Hummel B, Rodriguez E, Anderson M, Lewis C, Hargrove C, Ailawadi G, Goldman S, Khan J, Moront M, Grossi E, Roselli EE, Agnihotri A, Mack MJ, Smith JM, Th ourani VH, Duhay FG, Kocis MT, Ryan WH. Current era minimal-ly invasive aortic valve replacement: techniques and practice. J Th orac Cardiovasc Surg 2014;147(1):6–14.

64. Manatsathit W, Al-Hamid H, Leelasinjaroen P, Hashmi U, McCullough PA. Management of gastrointestinal bleeding in patients anticoagulated with dabigatran compared with warfarin: a retrospective, comparative case review. Cardiovasc Diagn Th er 2014;4(3):224–231.

65. Mathew V, Greason KL, Suri RM, Leon MB, Nkomo VT, Mack MJ, Rihal CS, Holmes DR Jr. Assessing the risk of aortic valve replacement for severe aortic stenosis in the transcatheter valve era. Mayo Clin Proc 2014;89(10):1427–1435.

66. McCullough PA. Practical experience using galectin-3 in heart failure. Clin Chem Lab Med 2014 May 8 [Epub ahead of print].

67. McCullough P, de Boer RA, Edelmann F, Lewis CM, Maisel AS. Utiliza-tion of galectin-3 in case management across the spectrum of heart failure. Rev Cardiovasc Med 2014;15(3):197–207.

68. McCullough PA, Beaver TM, Bennett-Guerrero E, Emmett M, Fonarow GC, Goyal A, Herzog CA, Kosiborod M, Palmer BF. Acute and chronic cardiovascular eff ects of hyperkalemia: new insights into prevention and clinical management. Rev Cardiovasc Med 2014;15(1):11–23.

69. McCullough PA, Fazel P, Choi JW. Screening, diagnosis, and management of CAD in asymptomatic diabetic patients. JACC Cardiovasc Imaging 2014;7(10):1011–1012.

70. McCullough PA, Jeff eries JL. Novel markers and therapies for patients with acute heart failure and renal dysfunction. Am J Med 2014 Nov 13 [Epub ahead of print].

71. McCullough PA, Kellum JA, Haase M, Müller C, Damman K, Murray PT, Cruz D, House AA, Schmidt-Ott KM, Vescovo G, Bagshaw SM, Hoste EA, Briguori C, Braam B, Chawla LS, Costanzo MR, Tumlin JA, Herzog CA, Mehta RL, Rabb H, Shaw AD, Singbartl K, Ronco C; Acute Dialysis

Quality Initiative (ADQI) Consensus Group. Pathophysiology of the cardiorenal syndromes: executive summary from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Blood Purif 2014;37(Suppl 2):2–13.

72. McCullough PA, Mehta A, Szerlip H. Improving detection of cardiac surgery-associated acute kidney injury. J Am Coll Cardiol 2014;64(25):2763–2764.

73. Morice MC, Serruys PW, Kappetein AP, Feldman TE, Ståhle E, Colombo A, Mack MJ, Holmes DR, Choi JW, Ruzyllo W, Religa G, Huang J, Roy K, Dawkins KD, Mohr F. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial. Circulation 2014;129(23):2388–2394.

74. Moussa ID, Klein LW, Shah B, Mehran R, Mack MJ, Brilakis ES, Reilly JP, Zoghbi G, Holper E, Stone GW; Society for Cardiovascular Angiog-raphy and Interventions. Consideration of a new defi nition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI). Catheter Cardiovasc Interv 2014;83(1):27–36.

75. Murthy R, DiMaio JM. Th oracic aortic endografting facilitates the resection of tumors infiltrating the aorta. J Thorac Cardiovasc Surg 2014;147(6):1748.

76. Neath SX, Jeff eries JL, Berger JS, Wu AH, McConnell JP, Boone JL, McCullough PA, Jesse RL, Maisel AS. Th e current and future landscape of urinary thromboxane testing to evaluate atherothrombotic risk. Rev Cardiovasc Med 2014;15(2):119–130.

77. Oliveira GH, Dupont M, Naftel D, Myers SL, Yuan Y, Tang WH, Gonzalez-Stawinski G, Young JB, Taylor DO, Starling RC. Increased need for right ventricular support in patients with chemotherapy-induced cardiomyopathy undergoing mechanical circulatory support: outcomes from the INTERMACS Registry (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 2014;63(3):240–248.

78. Palazzuoli A, Pellegrini M, Ruocco G, Martini G, Franci B, Campagna MS, Gilleman M, Nuti R, McCullough PA, Ronco C. Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial. Crit Care 2014;18(3):R134.

79. Pibarot P, Weissman NJ, Stewart WJ, Hahn RT, Lindman BR, McAndrew T, Kodali SK, Mack MJ, Thourani VH, Miller DC, Svensson LG, Herrmann HC, Smith CR, Rodés-Cabau J, Webb J, Lim S, Xu K, Hueter I, Douglas PS, Leon MB. Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort—an analysis. J Am Coll Cardiol 2014;64(13):1323–1334.

80. Pollak PM, Mack MJ, Holmes DR Jr. Quality, economics, and national guidelines for transcatheter aortic valve replacement. Prog Cardiovasc Dis 2014;56(6):610–618.

81. Pollock B, Hamman BL, Sass DM, da Graca B, Grayburn PA, Filardo G. Eff ect of gender and race on operative mortality after isolated coronary artery bypass grafting. Am J Cardiol 2014 Dec 18 [Epub ahead of print].

82. Puskas JD, Lazar HL, Mack MJ, Sabik JF 3rd, Paul Taggart D. State-of-the-art coronary artery bypass graft. Semin Th orac Cardiovasc Surg 2014;26(1):76–94.

83. Roberts CC, Parmar RJ, Grayburn PA, Patankar GR, Ko JM, Hamman BL, Roberts WC. Clues to diagnosing carcinoid heart disease as the cause of isolated right-sided heart failure. Am J Cardiol 2014;114(10):1623–1626.

84. Roberts CC, Snipes GJ, Ko JM, Roberts WC, Guileyardo JM. Nontrau-matic intracerebral hemorrhage unassociated with arterial aneurysmal rupture as a cause of sudden unexpected death. Proc (Bayl Univ Med Cent) 2014;27(4):331–333.

85. Roberts WC, Chung MS, Ko JM, Capehart JE, Hall SA. Morphologic features of cardiac sarcoidosis in native hearts of patients having cardiac transplantation. Am J Cardiol 2014;113(4):706–712.

86. Roberts WC, Ko JM, Benavides R Jr. Comparison of the frequency and level of serum total cholesterol >300 mg/dL in patients hospitalized at the same Texas hospital in a single month in 1993 and in 2013. Proc (Bayl Univ Med Cent) 2014;27(2):106–107.

Baylor University Medical Center Proceedings Volume 28, Number 2

269

87. Roberts WC, Roberts CC, Ko JM, Filardo G, Capehart JE, Hall SA. Morphologic features of the recipient heart in patients having car-diac transplantation and analysis of the congruence or incongruence between the clinical and morphologic diagnoses. Medicine (Baltimore) 2014;93(5):211–235.

88. Roberts WC, Rosenblatt RL, Ko JM, Grayburn PA, Kuiper JJ, Guileyardo JM. Cardiac restriction secondary to massive calcifi c deposits in the left ventricular cavity. Am J Cardiol 2014;113(8):1442–1446.

89. Roberts WC, Vowels TJ, Ko JM, Hebeler RF Jr. Gross and histologi-cal features of excised portions of posterior mitral leafl et in patients having operative repair of mitral valve prolapse and comments on the concept of missing (= ruptured) chordae tendineae. J Am Coll Cardiol 2014;63(16):1667–1674.

90. Rowin EJ, Maron BJ, Kiernan MS, Casey SA, Feldman DS, Hryniewicz KM, Chan RH, Harris KM, Udelson JE, DeNofrio D, Roberts WC, Maron MS. Advanced heart failure with preserved systolic function in nonobstructive hypertrophic cardiomyopathy: under-recognized subset of candidates for heart transplant. Circ Heart Fail 2014;7(6):967–975.

91. Rylski B, Blanke P, Beyersdorf F, Desai ND, Milewski RK, Siepe M, Kari FA, Czerny M, Carrel T, Schlensak C, Krüger T, Mack MJ, Brinkman WT, Mohr FW, Etz CD, Luehr M, Bavaria JE. How does the ascending aorta geometry change when it dissects? J Am Coll Cardiol 2014;63(13):1311–1319.

92. Sacks JD, Compton PA, Cura MA, Chamogeorgakis T. Surgical repair of postoperative lymphoceles in cardiac transplant patients following inguinal lymphangiography with methylene blue dye injection. J Vasc Interv Radiol 2014;25(4):656–658.

93. Sarmast S, Schussler JM, Ko JM, Roberts WC. Infective endocardi-tis superimposed on a massively calcifi ed severely stenotic congenitally bicuspid aortic valve. Proc (Bayl Univ Med Cent) 2014;27(1):37–38.

94. Schussler JM. Th e transradial approach in patients with acute coronary syndromes. In Kipshidze N, Fareed J, Rosen RJ, Dangas G, Serruys PW, eds. Urgent Interventional Th erapies. Chichester, UK: John Wiley & Sons, 2014: chapter 14.

95. Schussler JM, Th eologes TT, Hamman BL. Surgical coronary revascular-ization using an off -pump, no-touch technique: the Cyclone (Hexalon) experience. Open J Th orac Surg 2014;4:94–99.

96. Shahian DM, He X, Jacobs JP, Rankin JS, Welke KF, Edwards FH, Filardo G, Fazzalari FL, Furnary A, Kurlansky PA, Brennan JM, Badhwar V, O’Brien SM. Th e STS AVR+CABG composite score: a report of the STS Quality Measurement Task Force. Ann Th orac Surg 2014;97(5):1604–1609.

97. Shin HJ, Cho E, Lee HJ, Fung TT, Rimm E, Rosner B, Manson JE, Wheelan K, Hu FB. Instant noodle intake and dietary patterns are associated with distinct cardiometabolic risk factors in Korea. J Nutr 2014;144(8):1247–1255.

98. Shin HJ, McCullough PA. Focus on lipids: high-density lipoprotein cholesterol and its associated lipoproteins in cardiac and renal disease. Nephron Clin Pract 2014;127(1–4):158–164.

99. Shutze W, Gierman J, McQuade K, Pearl G, Smith B. Treatment of proximal vertebral artery disease. Vascular 2014;22(2):85–92.

100. Shutze WP Sr, Kane K, Fisher T, Daoud Y, Lassiter G, Lueking R, Nguyen E, Shutze W Jr, Pearl G, Smith B. Th e eff ect of laser wavelength on endothermal heat-induced thrombosis after endovenous laser ablation. J Vasc Surg 2014;60(6):1726.

101. Squiers JJ, Hutcheson KA, Th atcher JE, DiMaio JM. Cardiac stem cell therapy: checkered past, promising future? J Th orac Cardiovasc Surg 2014;148(6):3188–3193.

102. Suri RM, Th ourani VH, Englum BR, Rankin JS, Badhwar V, Svensson LG, Ailawadi G, Mack MJ, He M, Brennan JM, Schaff HV, Gammie JS. Th e expanding role of mitral valve repair in triple valve operations: contemporary North American outcomes in 8,021 patients. Ann Th orac Surg 2014;97(5):1513–1519.

103. Svensson LG, Blackstone EH, Rajeswaran J, Brozzi N, Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Tuzcu EM, Webb JG, Kapadia S, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Th ourani VH, Pichard AD, Bavaria JE, Herrmann HC, Williams MR, Babaliaros

V, Généreux P, Akin JJ; PARTNER Trial Investigators. Comprehensive analysis of mortality among patients undergoing TAVR: results of the PARTNER trial. J Am Coll Cardiol 2014;64(2):158–168.

104. Täger T, Hanholz W, Cebola R, Fröhlich H, Franke J, Doesch A, Katus HA, Wians FH Jr, Frankenstein L. Minimal important diff erence for 6-minute walk test distances among patients with chronic heart failure. Int J Cardiol 2014;176(1):94–98.

105. Tommaso CL, Fullerton DA, Feldman T, Dean LS, Hijazi ZM, Horlick E, Weiner BH, Zahn E, Cigarroa JE, Ruiz CE, Bavaria J, Mack MJ, Cameron DE, Bolman RM 3rd, Miller DC, Moon MR, Mukherjee D, Trento A, Aldea GS, Bacha EA; Society for Cardiovascular Angiography and Interventions; Americal Association for Th oracic Surgery; Americal College of Cardiology; Society for Th oracic Surgeons. SCAI/AATS/ACC/STS operator and institutional requirements for transcatheter valve repair and replacement. Part II. Mitral valve. J Th orac Cardiovasc Surg 2014;148(2):387–400. Also published in Ann Thorac Surg 2014;98(2):765–777 and J Am Coll Cardiol 2014;64(14):1515–1526 and Catheter Cardiovasc Interv 2014;84(4):567–580.

106. Toth PP, Shah PK, Wilkinson MJ, Davidson MH, McCullough PA. Use of microsomal triglyceride transfer protein inhibitors in patients with homozygous familial hypercholesterolemia: translating clinical trial experience into clinical practice. Rev Cardiovasc Med 2014;15(1):1–10.

107. Unger E, Porter T, Lindner J, Grayburn P. Cardiovascular drug delivery with ultrasound and microbubbles. Adv Drug Deliv Rev 2014;72:110–126.

108. van Diepen S, Brennan JM, Hafl ey GE, Reyes EM, Allen KB, Ferguson TB, Peterson ED, Williams JB, Gibson CM, Mack MJ, Kouchoukos NT, Alexander JH, Lopes RD. Endoscopic harvesting device type and outcomes in patients undergoing coronary artery bypass surgery. Ann Surg 2014;260(2):402–408.

109. Vowels TJ, Gonzalez-Stawinski GV, Ko JM, Trachiotis GD, Roberts BJ, Roberts CS, Roberts WC. Anomalous cord from the raphe of a con-genitally bicuspid aortic valve to the aortic wall producing either acute or chronic aortic regurgitation. J Am Coll Cardiol 2014;63(2):153–157.

110. Williams M, Kodali SK, Hahn RT, Humphries KH, Nkomo VT, Cohen DJ, Douglas PS, Mack M, McAndrew TC, Svensson L, Th ourani VH, Tuzcu EM, Weissman NJ, Kirtane AJ, Leon MB. Sex-related diff er-ences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol 2014;63(15):1522–1528.

COLON AND RECTAL SURGERYNote: See also Oncology for colon and rectal surgery articles related to colon cancer.111. Berho M, Wexner SD, Botero-Anug AM, Pelled D, Fleshman JW.

Histopathologic advantages of compression ring anastomosis healing as compared with stapled anastomosis in a porcine model: a blinded comparative study. Dis Colon Rectum 2014;57(4):506–513.

112. Fleshman JW, Beck DE, Hyman N, Wexner SD, Bauer J, George V; PRISM Study Group. A prospective, multicenter, randomized, controlled study of non-cross-linked porcine acellular dermal matrix fascial sublay for parastomal reinforcement in patients undergoing surgery for perma-nent abdominal wall ostomies. Dis Colon Rectum 2014;57(5):623–631.

113. Klos CL, Safar B, Hunt SR, Wise PE, Birnbaum EH, Mutch MG, Fleshman JW, Dharmarajan S. Accordion complication grading pre-dicts short-term outcome after right colectomy. J Surg Res 2014;190(2):510–516.

DERMATOLOGY114. Abramovits W. The Washington erythrodermics. Skinmed 2014;

12(5):318–319. 115. Abramovits W, Prato A, Vincent KD, Scheinfeld N, Gupta AK. MIRVASO

(brimonidine tartrate) topical gel 0.33%. Skinmed 2014;12(1):41–43. 116. Augustin M, Blome C, Costanzo A, Dauden E, Ferrandiz C, Girolomoni

G, Gniadecki R, Iversen L, Menter A, Michaelis-Wittern K, Morita A, Nakagawa H, Reich K. Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes. Br J Dermatol 2014;170(3):591–598.


270270

117. Cather JC. Psoriasis in children and women: addressing some special needs. Semin Cutan Med Surg 2014;33(2 Suppl 2):S42–S44.

118. Cather JC, Crowley JJ. Use of biologic agents in combination with other therapies for the treatment of psoriasis. Am J Clin Dermatol 2014;15(6):467–478.

119. Chitrapu P, Menter A, Readinger A, Patel M. Angiolymphoid hyperpla-sia with eosinophilia. Proc (Bayl Univ Med Cent) 2014;27(4):336–337.

120. Day A, Abramson AK, Patel M, Warren RB, Menter MA. Th e spectrum of oculocutaneous disease: Part II. Neoplastic and drug-related causes of oculocutaneous disease. J Am Acad Dermatol 2014;70(5):821.e1–e19.

121. Griffi n JR, Wetter DA, Camilleri MJ, Bridges AG. Blisters in a stem cell transplant patient. Int J Dermatol 2014;53(2):142–144.

122. Gupta AK, Cvetković D, Abramovits W, Vincent KD. LUZU (lulicon-azole) 1% cream. Skinmed 2014;12(2):90–93.

123. Gupta AK, Lyons DC, Abramovits W. Low-level laser/light therapy for androgenetic alopecia. Skinmed 2014;12(3):145–147.

124. Gupta AK, Simpson FC, Abramovits W, Scheinfeld N. Efinacon-azole 10% nail solution: a post-FDA approval update. Skinmed 2014;12(4):235–237.

125. Haugh I, Ryan C, Menter A. Biologics in practice: using biologic agents in combination with methotrexate in psoriasis therapy. Dermatologist 2014;21:28–31.

126. Horner ME, Abramson AK, Warren RB, Swanson S, Menter MA. Th e spectrum of oculocutaneous disease: Part I. Infectious, infl ammatory, and genetic causes of oculocutaneous disease. J Am Acad Dermatol 2014;70(5):795.e1–e25.

127. Jackson JM, Fowler J, Moore A, Jarratt M, Jones T, Meadows K, Steinhoff M, Rudisill D, Leoni M; Brimonidine Phase III Study Group. Improve-ment in facial erythema within 30 minutes of initial application of brimonidine tartrate in patients with rosacea. J Drugs Dermatol 2014;13(6):699–704.

128. Kerdel FA, Menter A, Micheletti RG. Hidradenitis suppurativa: up-date on diagnosis and treatment. Introduction. Semin Cutan Med Surg 2014;33(3 Suppl):S47.

129. Kerdel FA, Menter A, Micheletti RG. What you should know about hidradenitis suppurativa (HS): information for patients. Semin Cutan Med Surg 2014;33(3 Suppl):S60–S61.

130. Kivelevitch D. A report from the American Academy of Dermatology 72nd annual meeting. Psoriasis Review 2014;10(1):8–18.

131. Kivelevitch D, Mansouri B, Menter A. Long term effi cacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis. Biologics 2014;8:169–182.

132. Kivelevitch D, Sharma S, Mansouri B, Patel M, Ryan C, Menter A, Obermoser G. FC20: Immune signatures of psoriasis. Br J Dermatol 2014;171:e105–e173.

133. Kivelevitch DN, Ryan C, Menter A. Th e use of tumor necrosis factor inhibitors in pregnancy: what is the evidence? J Am Acad Dermatol 2014;71(4):829–831.

134. Mansouri B, Kivelevitch D, Benjegerdes K, Richards L, Obermoser G, Ryan C, Schussler J, Menter A. P69: Pilot data on coronary artery calcium score utilization to improve risk stratifi cation in patients with moderate to severe psoriasis. Br J Dermatol 2014;171:e105–e152.

135. Mansouri B, Menter A. Complementary data for long-term infl iximab use in psoriasis. J Am Acad Dermatol 2014;71(3):591.

136. Mansouri B, Richards L, Menter A. Treatment of two patients with generalised pustular psoriasis with the interleukin-1 beta inhibitor gevoki-zumab. Br J Dermatol 2014 Dec 15 [Epub ahead of print].

137. Menter A. Recognizing and managing comorbidities and compli-cations in hidradenitis suppurativa. Semin Cutan Med Surg 2014;33(3 Suppl):S54–S56.

138. Menter A, Papp KA, Tan H, Tyring S, Wolk R, Buonanno M. Effi cacy of tofacitinib, an oral janus kinase inhibitor, on clinical signs of moderate-to-severe plaque psoriasis in diff erent body regions. J Drugs Dermatol 2014;13(3):252–256.

139. Papp K, Leonardi C, Menter A, Th ompson EH, Milmont CE, Kricorian G, Nirula A, Klekotka P. Safety and effi cacy of brodalumab for psoriasis after 120 weeks of treatment. J Am Acad Dermatol 2014;71(6):1183–1190.e3.

140. Papp K, Menter A, Strober B, Kricorian G, Th ompson EH, Milmont CE, Nirula A, Klekotka P. Effi cacy and safety of brodalumab in sub-populations of patients with diffi cult-to-treat moderate-to-severe plaque psoriasis. J Am Acad Dermatol 2014 Dec 29 [Epub ahead of print].

141. Patel M, Freeman NR, Dhaliwal S, Wright N, Daoud Y, Ryan C, Dibella AV, Menter A. Th e prevalence of Dupuytren contractures in patients with psoriasis. Clin Exp Dermatol 2014;39(8):894–899.

142. Patel M, Menter A. Reply: Genital edema in Crohn’s disease. J Am Acad Dermatol 2014;70(2):385.

143. Prater EF, Day A, Patel M, Menter A. A retrospective analysis of 72 patients on prior efalizumab subsequent to the time of voluntary market withdrawal in 2009. J Drugs Dermatol 2014;13(6):712–718.

144. Ryan C, Kelleher J, Fagan MF, Rogers S, Collins P, Barker JN, Allen M, Hagan R, Renfro L, Kirby B. Genetic markers of treatment response to tumour necrosis factor-α inhibitors in the treatment of psoriasis. Clin Exp Dermatol 2014;39(4):519–524.

145. Ryan C, Kirby B. Psoriasis is a systemic disease with multiple cardiovas-cular and metabolic co-morbidities. Clin Dermatol 2014;71:829–831.

146. Ryan C, Korman NJ, Gelfand JM, Lim HW, Elmets CA, Feldman SR, Gottlieb AB, Koo JY, Lebwohl M, Leonardi CL, Van Voorhees AS, Bhushan R, Menter A. Research gaps in psoriasis: opportunities for fu-ture studies. J Am Acad Dermatol 2014;70(1):146–167.

147. Ryan C, Leonardi C. Ustekinumab. In Weinberg J, Lebwohl M, eds. Advances in Psoriasis: A Multisystemic Guide. Springer, 2014.

148. Ryan C, Menter A. Ponesimod—a future oral therapy for psoriasis? Lancet 2014;384(9959):2006–2008.

149. Ryan C, Menter A. Recent and future developments in targeted therapy. In Sterry W, Sabat R, Phillip S, eds. Psoriasis: Diagnosis and Management. Wiley-Blackwell, 2014: chapter 32.

150. Silverberg JI, Becker L, Kwasny M, Menter A, Cordoro KM, Paller AS. Central obesity and high blood pressure in pediatric patients with atopic dermatitis. JAMA Dermatol 2014 Dec 23 [Epub ahead of print].

151. Trickett C, Menter A. Managing rosacea. J Derm Physic Assist 2014;8(4):17.

152. Udovenko O, Griffi n JR, Elston DM. Biopsy diagnoses of clinically atypi-cal pigmented lesions of the head and neck in adults. Am J Dermatopathol 2014;36(10):829–831.

153. Wilder EG, Patel M, Hebeler K, Menter A. Ustekinumab treatment for psoriasis in 119 patients maintained on therapy for a minimum of one year: a review. J Drugs Dermatol 2014;13(8):905–910.

154. Woff ord J, Menter A. Ustekinumab for the treatment of psoriatic arthri-tis. Expert Rev Clin Immunol 2014;10(2):189–202.

155. Zaghi D, Readinger A, Menter A. Polymorphic plaques involving the face and extremities. JAMA Dermatol 2014;150(6):643–644.

156. Zaghi D, Ryan C. Psoriasis: what every resident needs to know. Directions in Residency 2014(Summer):1–3.

157. Zaghi D, Witheiler D, Menter AM. Petechial eruption on fi ngers. JAMA Dermatol 2014;150(12):1353–1354.

ENDOCRINOLOGYNote: See also Transplantation for articles on islet cell transplantation. 158. Bain TM, Jones ML, O’Brian CA, Lipman R. Feasibility of smart-

phone-delivered diabetes self-management education and training in an underserved urban population of adults. J Telemed Telecare 2014 July 24 [Epub ahead of print].

159. Gough SC, Bode B, Woo V, Rodbard HW, Linjawi S, Poulsen P, Damgaard LH, Buse JB; NN9068-3697 (DUAL-I) trial investigators. Effi cacy and safe-ty of a fi xed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes. Lancet Diabetes Endocrinol 2014;2(11):885–893.

160. Herrin J, da Graca B, Aponte P, Stanek G, Fullerton C, Hollander P, Ballard D. Impact of an EHR-based diabetes management form on qual-ity and outcomes of diabetes care in primary care practices. Am J Med Qual 2014 Jan 7 [Epub ahead of print].

161. Niswender K, Piletic M, Andersen H, Conradsen Hiort L, Hollander P. Weight change upon once-daily initiation of insulin detemir with or


271

without dietary intervention in overweight or obese insulin-naïve indi-viduals with type 2 diabetes: results from the DIET trial. Diabetes Obes Metab 2014;16(2):186–192.

162. Yki-Järvinen H, Bergenstal R, Ziemen M, Wardecki M, Muehlen- Bartmer I, Boelle E, Riddle MC; EDITION 2 Study Investigators. New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 2). Diabetes Care 2014;37(12):3235–3243.

GASTROENTEROLOGY Note: See also Oncology for research on colon cancer.163. Ford AC, Moayyedi P, Lacy BE, Lembo AJ, Saito YA, Schiller LR,

Soff er EE, Spiegel BM, Quigley EM; Task Force on the Management of Functional Bowel Disorders. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol 2014;109(Suppl 1):S2–S26.

164. Ford AC, Quigley EM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, Soff er EE, Spiegel BM, Moayyedi P. Effi cacy of prebiotics, probiot-ics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol 2014;109(10):1547–1561.

165. Ford AC, Quigley EM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, Soff er EE, Spiegel BM, Moayyedi P. Eff ect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systemat-ic review and meta-analysis. Am J Gastroenterol 2014;109(9):1350–1365.

166. Han J, Th eiss AL. Stat3: friend or foe in colitis and colitis-associated cancer? Infl amm Bowel Dis 2014;20(12):2405–2411.

167. Han J, Yu C, Souza RF, Th eiss AL. Prohibitin 1 modulates mitochondrial function of Stat3. Cell Signal 2014;26(10):2086–2095.

168. Kumar S, Asrani SK, Kamath PS. Epidemiology, diagnosis and early patient management of esophagogastric hemorrhage. Gastroenterol Clin North Am 2014;43(4):765–782.

169. Moayyedi P, Quigley EM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, Soff er EE, Spiegel BM, Ford AC. Th e eff ect of fi ber supplementation on irritable bowel syndrome: a systematic review and meta-analysis. Am J Gastroenterol 2014;109(9):1367–1374.

170. Schiller LR, Pardi DS, Spiller R, Semrad CE, Surawicz CM, Giannella RA, Krejs GJ, Farthing MJ, Sellin JH. Gastro 2013 APDW/WCOG Shanghai working party report: chronic diarrhea: defi nition, classifi ca-tion, diagnosis. J Gastroenterol Hepatol 2014;29(1):6–25.

GERONTOLOGY171. American Geriatrics Society Ethics Committee and Clinical Practice

and Models of Care Committee. American Geriatrics Society feed-ing tubes in advanced dementia position statement. J Am Geriatr Soc 2014;62(8):1590–1593.

172. Courtney MR, Spivey C, Daniel KM. Helping patients make better decisions: how to apply behavioral economics in clinical practice. Patient Prefer Adherence 2014;8:1503–1512.

173. Daniel K, Upshaw M, Plank L, Nunnelee J. Dementia screening and management practices of advanced practice registered nurses in Texas. J Nurse Practit 2014;10(5):308–315.

HEALTH CARE RESEARCH AND IMPROVEMENT174. Abujarour R, Bennett M, Valamehr B, Lee TT, Robinson M, Robbins D,

Le T, Lai K, Flynn P. Myogenic diff erentiation of muscular dystrophy-specifi c induced pluripotent stem cells for use in drug discovery. Stem Cells Transl Med 2014;3(2):149–160.

175. Allison JT, Ballard DJ. Governance. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:3–12.

176. Allison JT, Ballard DJ. Leadership. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:13–16.

177. Allison JT, Fullerton C, Chabira A. Baylor Health Care System’s journey to provide equitable care. Front Health Serv Manage 2014;30(3):2–15.

178. Ballard DJ, Convery P, Brock G. Organizational structures. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:17–22.

179. Collinsworth A, Vulimiri M, Snead C, Walton J. Community health workers in primary care practice: redesigning health care delivery systems to extend and improve diabetes care in underserved populations. Health Promot Pract 2014;15(2 Suppl):51S–61S.

180. Collinsworth AW, Priest EL, Campbell CR, Vasilevskis EE, Masica AL. A review of multifaceted care approaches for the prevention and mitiga-tion of delirium in intensive care units. J Intensive Care Med 2014 Oct 27 [Epub ahead of print].

181. Compton J, Kennerly D. Safe care. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:113–120.

182. Convery P, Couch CE. Physician leadership. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:35–42.

183. Couch CE, Winter FD, Roberts WL. Driving STEEEP care across a physician provider network. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:99–111.

184. Couch CE, Winter FD, Roberts WL. Engaging STEEEP care in an accountable care organization. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:217–226.

185. Dieckert JP, Henry M. Applications of Lean to STEEEP care improve-ment. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:65–74.

186. Dieckert JP, Rohack JJ. Driving STEEEP care through an owned and operated health plan. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:209–216.

187. Fleming NS, Ballard DJ. Conclusion. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:239–244.

188. Fleming NS, Becker ER, Culler SD, Cheng D, McCorkle R, da Graca B, Ballard DJ. Th e impact of electronic health records on workfl ow and fi nancial measures in primary care practices. Health Serv Res 2014;49(1 Pt 2):405–420.

189. Fleming NS, Masica A, McCarthy I. Evaluation of clinical, economic, and fi nancial outcomes. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:85–92.

190. Franklin EW IV. Surgical services. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:191–198.

191. Fullerton CT. Equitable care. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:133–138.

192. Gilder RE. Missed opportunity related to statistical methods. AORN J 2014;99(6):674–675.

193. Green RT, Kennerly D. Effi cient care. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:127–132.

194. Holtz K, de Vol E. Alignment, goal setting, and incentives. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:23–28.

195. Horwitz LI, Masica AL, Auerbach AD. Introducing Choosing Wisely®: next steps in improving healthcare value. J Hosp Med 2014 Dec 30 [Epub ahead of print].

196. Kennerly D, Cox MC. STEEEP care operations. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:81–84.

197. Kennerly D, Valdes M, Nicewander D, Green RT. STEEEP analytics. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care Sys-tem’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:75–80.


272272

198. Kennerly DA, Kudyakov R, da Graca B, Saldaña M, Compton J, Nicewander D, Gilder R. Characterization of adverse events detected in a large health care delivery system using an enhanced global trigger tool over a fi ve-year interval. Health Serv Res 2014;49(5):1407–1425.

199. Lamba AR, Linn K, Fletcher KE. Identifying patient safety prob-lems during team rounds: an ethnographic study. BMJ Qual Saf 2014;23(8):667–669.

200. Leonard BM, Cooksey WB, Sanborn MD, Valentine M, Mack MJ, Brown DL, Wheelan KR, Vish N. Cardiovascular services. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:151–162.

201. Leonard BM, Shutts C, Fleming NS. STEEEP Academy. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:53–64.

202. Lewis MA, Bann CM, Karns SA, Hobbs CL, Holt S, Brenner J, Fleming N, Johnson P, Langwell K, Peek ME, Burton JA, Hoerger TJ, Clark NM, Kamerow DB. Cross-site evaluation of the Alliance to Reduce Disparities in Diabetes: clinical and patient-reported outcomes. Health Promot Pract 2014;15(2 Suppl):92S–102S.

203. Luquire R. Nurse leadership. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:43–52.

204. Luquire R, Baird RW. Critical care services. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:171–176.

205. Masica A. Timely and eff ective care. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:121–126.

206. McCarthy IM, Robinson C, Huq S, Philastre M, Fine RL. Cost savings from palliative care teams and guidance for a fi nancially viable palliative care program. Health Serv Res 2014 Jul 15 [Epub ahead of print].

207. McWhorter JB III. Driving STEEEP care across a multihospital system. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:93–98.

208. McWhorter JB, Convery P, Bell CE. Diabetes Health and Wellness Insti-tute: an escape fi re model for STEEEP care. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:227–238.

209. Miller AM, Stone MJ, Jones JL. Oncology services. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:177–189.

210. Nuss TD. Patient-centered care. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:139–149.

211. Polo FE, Mabrey JD, Jones A, Garison JJ. Orthopedic services. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:199–208.

212. Pope B, Deshmukh A, Johnson A, Rohack J. Multilateral contracting and prevention. Health Econ 2014;23(4):397–409.

213. Savelsbergh F, Green RT, Ballard DJ. Financial leadership. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:29–34.

214. Stockbridge EL, Philpot LM, Pagán JA. Patient-centered medical home features and expenditures by medicare benefi ciaries. Am J Manag Care 2014;20(5):379–385.

215. Walker KL, Kirillova O, Gillespie SE, Hsiao D, Pishchalenko V, Pai AK, Puro JE, Plumley R, Kudyakov R, Hu W, Allisany A, McBurnie M, Kurtz SE, Hazlehurst BL. Using the CER Hub to ensure data quality in a multi-institution smoking cessation study. J Am Med Inform Assoc 2014;21(6):1129–1135.

216. Williams RJ, Masica AL, McBurnie M, Solberg L, Bailey SR, Hazlehurst B, Kurtz SE, Williams AE, Puro JE, Stevens VJ. Documentation of use of the 5As for smoking cessation by primary care physicians across six health care delivery systems. Am J Manag Care 2014;20(3):e35–e42.

217. Zenarosa NR, Luquire R, Powell KK. Emergency services. In Ballard DJ, ed. Achieving STEEEP Health Care: Baylor Health Care System’s Quality Improvement Journey. Boca Raton: CRC Press, 2014:163–170.

HEPATOLOGYNote: See also Transplantation.218. Asrani SK. Liver transplantation for nonalcoholic steatohepatitis. Clin

Gastroenterol Hepatol 2014;12(3):403–404. 219. Asrani SK, Davis GL. Impact of birth cohort screening for hepatitis C.

Curr Gastroenterol Rep 2014;16(4):381.220. Asrani SK, Kamath PS. Neutrophil dysfunction in patients with cirrhosis.

Aliment Pharmacol Th er 2014;40(8):986. 221. Asrani SK, Kamath PS. Prediction of early mortality after variceal bleed-

ing: score one more for MELD. Gastroenterology 2014;146(2):337–339. 222. Asrani SK, O’Leary JG. Acute-on-chronic liver failure. Clin Liver Dis

2014;18(3):561–574. 223. Asrani SK, Talwalkar JA, Kamath PS, Shah VH, Saracino G, Jennings

L, Gross JB, Venkatesh S, Ehman RL. Role of magnetic resonance elas-tography in compensated and decompensated liver disease. J Hepatol 2014;60(5):934–939.

224. Bajaj JS, O’Leary JG, Reddy KR, Wong F, Biggins SW, Patton H, Fallon MB, Garcia-Tsao G, Maliakkal B, Malik R, Subramanian RM, Th acker LR, Kamath PS, North American Consortium For Th e Study Of End-Stage Liver Disease. Survival in infection-related acute-on-chronic liver failure is defi ned by extrahepatic organ failures. Hepatology 2014;60(1):250–256.

225. Batra S, Machicao VI, Bynon JS, Mehta S, Tanikella R, Krowka MJ, Zacks S, Trotter J, Roberts KE, Brown RS, Kawut SM, Fallon MB; Pulmonary Vascular Complications of Liver Disease Group. Th e im-pact of left ventricular hypertrophy on survival in candidates for liver transplantation. Liver Transpl 2014;20(6):705–712.

226. Burton JR Jr, O’Leary JG, Verna EC, Saxena V, Dodge JL, Stravitz RT, Levitsky J, Trotter JF, Everson GT, Brown RS Jr, Terrault NA. A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy. J Hepatol 2014;61(3):508–514.

227. Di Bisceglie AM, Lok AS, Martin P, Terrault N, Perrillo RP, Hoofnagle JH. Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: Just the tip of the iceberg? Hepatology 2014 Nov 21 [Epub ahead of print].

228. Goldberg DS, Krok K, Batra S, Trotter JF, Kawut SM, Fallon MB. Impact of the hepatopulmonary syndrome MELD exception policy on outcomes of patients after liver transplantation: an analysis of the UNOS database. Gastroenterology 2014;146(5):1256–1265.e1.

229. Gonzalez SA. Acute Liver Failure: Diagnosis and Management, 5th ed. London: BMJ Point of Care, 2014.

230. Gonzalez SA. Antiviral therapy for hepatitis C in liver transplant candi-dates. HCV Next 2014;1(2):30–32.

231. Gonzalez SA. Novel biomarkers for hepatocellular carcinoma surveil-lance: has the future arrived? Hepatobiliary Surg Nutr 2014;3(6):410–414.

232. Gonzalez SA. Treatment of hepatitis C following liver transplantation in the era of direct acting antivirals. HCV Next 2014;1(8):22–26.

233. Gonzalez SA, Perrillo R. Immunopathogenesis of chronic hepatitis B and the clinical events that shape its natural history. In Gershwin ME, Vierling JM, Manns MP, eds. Liver Immunology: Principles and Practice, 2nd ed. Springer, 2014:191–206.

234. Hwang JP, Barbo AG, Perrillo RP. Hepatitis B reactivation during c ancer chemotherapy: an international survey of the membership of the American Association for the Study of Liver Diseases. J Viral Hepat 2014 Sep 15 [Epub ahead of print].

235. O’Leary JG, Reddy KR, Wong F, Kamath PS, Patton HM, Biggins SW, Fallon MB, Garcia-Tsao G, Subramanian RM, Malik R, Th acker LR, Bajaj JS; North American Consortium for the Study of End-Stage Liver Disease. Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis. Clin Gastroenterol Hepatol 2014 Aug 12 [Epub ahead of print].

236. Perrillo RP, Gish R, Falck-Ytter YT. American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. Gastroenterology 2014 Oct 31 [Epub ahead of print].

237. Rahimi RS, Guntipalli P, Rockey DC. Worldwide practices for pharma-cologic therapy in esophageal variceal hemorrhage. Scand J Gastroenterol 2014;49(2):131–137.


273

238. Rahimi RS, Rockey DC. Hepatic encephalopathy: how to test and treat. Curr Opin Gastroenterol 2014;30(3):265–271.

239. Rahimi RS, Singal AG, Cuthbert JA, Rockey DC. Lactulose vs poly-ethylene glycol 3350-electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial. JAMA Intern Med 2014;174(11):1727–1733.

240. Seetharam A, Perrillo R, Gish R. Immunosuppression in patients with chronic hepatitis B. Curr Hepatol Rep 2014;13:235–244.

241. Smith MT, Rase B, Woods A, Trotter J, Gipson M, Kondo K, Ray C, Durham J. Risk of hernia incarceration following transjugular intrahepat-ic portosystemic shunt placement. J Vasc Interv Radiol 2014;25(1):58–62.

242. Valley MA, Trotter JF, Th omas D, Ginde AA, Lownenstein SR, Honigman B. Th e relationship between hepatopulmonary syndrome and altitude. Can J Gastroenterol Hepatol 2014;28(3):140–142.

243. Wong F, O’Leary JG, Reddy KR, Kamath PS, Garcia-Tsao G, Maliakkal B, Subramanian R, Th acker L, Bajaj J; North American Consortium for the Study of End-Stage Liver Disease. A cut-off serum creatinine value of 1.5mg/dl for AKI—to be or not to be. J Hepatol 2014 Dec 5 [Epub ahead of print].

IMMUNOLOGY/BASIC SCIENCES 244. Agrawal V, Woo JH, Mauldin JP, Stone EM, Meininger CJ, Jo C,

Kleypas K, Frenkel EP, Frankel AE. In-vivo evaluation of human re-combinant co-arginase against A375 melanoma xenografts. Melanoma Res 2014;24(6):556–567.

245. Alsina L, Israelsson E, Altman MC, Dang KK, Ghandil P, Israel L, von Bernuth H, Baldwin N, Qin H, Jin Z, Banchereau R, Anguiano E, Ionan A, Abel L, Puel A, Picard C, Pascual V, Casanova JL, Chaussabel D. A narrow repertoire of transcriptional modules responsive to pyogenic bacteria is impaired in patients carrying loss-of-function mutations in MYD88 or IRAK4. Nat Immunol 2014;15(12):1134–1142.

246. Arreola A, Cowey CL, Coloff JL, Rathmell JC, Rathmell WK. HIF1α and HIF2α exert distinct nutrient preferences in renal cells. PLoS One 2014;9(5):e98705.

247. Ashktorab H, Daremipouran M, Goel A, Varma S, Leavitt R, Sun X, Brim H. DNA methylome profi ling identifi es novel methylated genes in African American patients with colorectal neoplasia. Epigenetics 2014;9(4):503–512.

248. Bachanova V, Marks DI, Zhang MJ, Wang H, de Lima M, Aljurf MD, Arellano M, Artz AS, Bacher U, Cahn JY, Chen YB, Copelan EA, Drobyski WR, Gale RP, Greer JP, Gupta V, Hale GA, Kebriaei P, Lazarus HM, Lewis ID, Lewis VA, Liesveld JL, Litzow MR, Loren AW, Miller AM, Norkin M, Oran B, Pidala J, Rowe JM, Savani BN, Saber W, Vij R, Waller EK, Wiernik PH, Weisdorf DJ. Ph+ ALL patients in fi rst complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease. Leukemia 2014;28(3):658–665.

249. Banchereau R, Baldwin N, Cepika AM, Athale S, Xue Y, Yu CI, Metang P, Cheruku A, Berthier I, Gayet I, Wang Y, Ohouo M, Snipes L, Xu H, Obermoser G, Blankenship D, Oh S, Ramilo O, Chaussabel D, Banchereau J, Palucka K, Pascual V. Transcriptional specialization of human dendritic cell subsets in response to microbial vaccines. Nat Commun 2014;5:5283.

250. Barker JC, Barker AD, Bills J, Huang J, Wight-Carter M, Delgado I, Noble DL, Huang LJ, Porteus MH, Davis KE. Genome editing of mouse fi broblasts by homologous recombination for sustained secretion of PDGF-B and augmentation of wound healing. Plast Reconstr Surg 2014;134(3):389e–401e.

251. Blankley S, Graham CM, Howes A, Bloom CI, Berry MP, Chaussabel D, Pascual V, Banchereau J, Lipman M, O’Garra A. Identifi cation of the key diff erential transcriptional responses of human whole blood fol-lowing TLR2 or TLR4 ligation in-vitro. PLoS One 2014;9(5):e97702.

252. Campbell JD, Kell SA, Kozy HM, Lum JA, Sweetwood R, Chu M, Cunningham CR, Salamon H, Lloyd CM, Coff man RL, Hessel EM. A limited CpG-containing oligodeoxynucleotide therapy regimen induces sustained suppression of allergic airway infl ammation in mice. Th orax 2014;69(6):565–573.

253. Cao RG, Suarez NM, Obermoser G, Lopez SM, Flano E, Mertz SE, Albrecht RA, García-Sastre A, Mejias A, Xu H, Qin H, Blankenship D, Palucka K, Pascual V, Ramilo O. Diff erences in antibody responses between trivalent inactivated infl uenza vaccine and live attenuated in-fl uenza vaccine correlate with the kinetics and magnitude of interferon signaling in children. J Infect Dis 2014;210(2):224–233.

254. Chaussabel D, Baldwin N. Democratizing systems immunology with modular transcriptional repertoire analyses. Nat Rev Immunol 2014;14(4):271–280.

255. Chiche L, Jourde-Chiche N, Whalen E, Presnell S, Gersuk V, Dang K, Anguiano E, Quinn C, Burtey S, Berland Y, Kaplanski G, Harle JR, Pascual V, Chaussabel D. Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures. Arthritis Rheumatol 2014;66(6):1583–1595.

256. Disis ML, Palucka K. Evaluation of cancer immunity in mice. Cold Spring Harb Protoc 2014;2014(3):231–234.

257. Duluc D, Banchereau R, Gannevat J, Th ompson-Snipes L, Blanck JP, Zurawski S, Zurawski G, Hong S, Rossello-Urgell J, Pascual V, Baldwin N, Stecher J, Carley M, Boreham M, Oh S. Transcriptional fi ngerprints of an-tigen-presenting cell subsets in the human vaginal mucosa and skin refl ect tissue-specifi c immune microenvironments. Genome Med 2014;6(11):98.

258. Duluc D, Joo H, Ni L, Yin W, Upchurch K, Li D, Xue Y, Klucar P, Zurawski S, Zurawski G, Oh S. Induction and activation of human Th 17 by targeting antigens to dendritic cells via dectin-1. J Immunol 2014;192(12):5776–5788.

259. Ellyard JI, Jerjen R, Martin JL, Lee AY, Field MA, Jiang SH, Cappello J, Naumann SK, Andrews TD, Scott HS, Casarotto MG, Goodnow CC, Chaitow J, Pascual V, Hertzog P, Alexander SI, Cook MC, Vinuesa CG. Identifi cation of a pathogenic variant in TREX1 in early-onset cerebral systemic lupus erythematosus by whole-exome sequencing. Arthritis Rheumatol 2014;66(12):3382–3386.

260. Epaulard O, Adam L, Poux C, Zurawski G, Salabert N, Rosenbaum P, Dereuddre-Bosquet N, Zurawski S, Flamar AL, Oh S, Romain G, Chapon C, Banchereau J, Lévy Y, Le Grand R, Martinon F. Macrophage- and neutrophil-derived TNF-α instructs skin Langerhans cells to prime antiviral immune responses. J Immunol 2014;193(5):2416–2426.

261. Gaviria-Agudelo C, Carter K, Tareen N, Pascual V, Copley LA. Gene expression analysis of children with acute hematogenous osteomyelitis caused by methicillin-resistant Staphylococcus aureus: correlation with clinical severity of illness. PLoS One 2014;9(7):e103523.

262. Gorvel L, Textoris J, Banchereau R, Ben Amara A, Tantibhedhyangkul W, von Bargen K, Ka MB, Capo C, Ghigo E, Gorvel JP, Mege JL. Intracel-lular bacteria interfere with dendritic cell functions: role of the type I interferon pathway. PLoS One 2014;9(6):e99420.

263. Joo H, Li D, Dullaers M, Kim TW, Duluc D, Upchurch K, Xue Y, Zurawski S, Le Grand R, Liu YJ, Kuroda M, Zurawski G, Oh S. C-type lectin-like receptor LOX-1 promotes dendritic cell-mediated class-switched B cell responses. Immunity 2014;41(4):592–604.

264. Lee S, Cantarel B, Henrissat B, Gevers D, Birren BW, Huttenhower C, Ko G. Gene-targeted metagenomic analysis of glucan-branching en-zyme gene profi les among human and animal fecal microbiota. ISME J 2014;8(3):493–503.

265. Li G, Cheng M, Nunoya J, Cheng L, Guo H, Yu H, Liu YJ, Su L, Zhang L. Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice. PLoS Pathog 2014;10(7):e1004291.

266. Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, Davis C, Schmidt DS, Johnson SE, Milton A, Rajam G, Kasturi S, Carlone GM, Quinn C, Chaussabel D, Palucka AK, Mulligan MJ, Ahmed R, Stephens DS, Nakaya HI, Pulendran B. Molecular signatures of antibody responses derived from a systems biology study of fi ve human vaccines. Nat Immunol 2014;15(2):195–204.

267. Link A, Goel A. microRNAs as noninvasive biomarker for gastrointestinal cancers: a step closer to reality. In Makowski GS, ed. Advances in Clinical Chemistry. Elsevier, 2014:221–268.

268. Liu Y, Lu N, Yuan B, Weng L, Wang F, Liu YJ, Zhang Z. Th e interac-tion between the helicase DHX33 and IPS-1 as a novel pathway to sense


274274

double-stranded RNA and RNA viruses in myeloid dendritic cells. Cell Mol Immunol 2014;11(1):49–57.

269. Looft T, Allen HK, Cantarel BL, Levine UY, Bayles DO, Alt DP, Henrissat B, Stanton TB. Bacteria, phages and pigs: the eff ects of in-feed antibiotics on the microbiome at diff erent gut locations. ISME J 2014;8(8):1566–1576.

270. Lu H, Lu N, Weng L, Yuan B, Liu YJ, Zhang Z. DHX15 senses double-stranded RNA in myeloid dendritic cells. J Immunol 2014;193(3):1364–1372.

271. Melum GR, Farkas L, Scheel C, Van Dieren B, Gran E, Liu YJ, Johansen FE, Jahnsen FL, Baekkevold ES. A thymic stromal lymphopoietin- responsive dendritic cell subset mediates allergic responses in the upper airway mucosa. J Allergy Clin Immunol 2014;134(3):613–621.e7.

272. Mitsui H, Suárez-Fariñas M, Gulati N, Shah KR, Cannizzaro MV, Coats I, Felsen D, Krueger JG, Carucci JA. Gene expression profi ling of the leading edge of cutaneous squamous cell carcinoma: IL-24-driven MMP-7. J Invest Dermatol 2014;134(5):1418–1427.

273. Moreira L, Muñoz J, Cuatrecasas M, Quintanilla I, Leoz ML, Carballal S, Ocaña T, López-Cerón M, Pellise M, Castellví-Bel S, Jover R, Andreu M, Carracedo A, Xicola RM, Llor X, Boland CR, Goel A, Castells A, Balaguer F. Prevalence of somatic mutl homolog 1 promoter hypermeth-ylation in Lynch syndrome colorectal cancer. Cancer 2014 Dec 29 [Epub ahead of print].

274. Palucka K, Banchereau J. SnapShot: cancer vaccines. Cell 2014;157(2):516–516.e1.

275. Paria N, Cho TJ, Choi IH, Kamiya N, Kayembe K, Mao R, Margraf RL, Obermosser G, Oxendine I, Sant DW, Song MH, Stevenson DA, Viskochil DH, Wise CA, Kim HK, Rios JJ. Neurofi bromin defi ciency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1. J Bone Miner Res 2014;29(12):2636–2342.

276. Ray A, Tian Z, Das DS, Coff man RL, Richardson P, Chauhan D, Anderson KC. A novel TLR-9 agonist C792 inhibits plasmacytoid den-dritic cell-induced myeloma cell growth and enhance cytotoxicity of bortezomib. Leukemia 2014;28(8):1716–1724.

277. Rodriguez-Pla A, Patel P, Maecker HT, Rossello-Urgell J, Baldwin N, Bennett L, Cantrell V, Baisch J, Punaro M, Gotte A, Nassi L, Wright T, Palucka AK, Banchereau J, Pascual V. IFN priming is necessary but not suffi cient to turn on a migratory dendritic cell program in lupus monocytes. J Immunol 2014;192(12):5586–5598.

278. Rongvaux A, Willinger T, Martinek J, Strowig T, Gearty SV, Teichmann LL, Saito Y, Marches F, Halene S, Palucka AK, Manz MG, Flavell RA. Development and function of human innate immune cells in a human-ized mouse model. Nat Biotechnol 2014;32(4):364–372.

279. Sanmukhani J, Satodia V, Trivedi J, Patel T, Tiwari D, Panchal B, Goel A, Tripathi CB. Effi cacy and safety of curcumin in major depressive dis-order: a randomized controlled trial. Phytother Res 2014;28(4):579–585.

280. Schmitt N, Bentebibel SE, Ueno H. Phenotype and functions of memory Tfh cells in human blood. Trends Immunol 2014;35(9):436–442.

281. Schmitt N, Liu Y, Bentebibel SE, Munagala I, Bourdery L, Venuprasad K, Banchereau J, Ueno H. Th e cytokine TGF-beta co-opts signaling via STAT3-STAT4 to promote the diff erentiation of human TFH cells. Nat Immunol 2014;15(9):856–865.

282. Schmitt N, Liu Y, Bentebibel SE, Munagala I, Bourdery L, Venuprasad K, Banchereau J, Ueno H. Th e cytokine TGF-beta co-opts signaling via STAT3-STAT4 to promote the diff erentiation of human TFH cells. Nat Immunol 2014;15(9):856–865.

283. Sha W, Mitoma H, Hanabuchi S, Bao M, Weng L, Sugimoto N, Liu Y, Zhang Z, Zhong J, Sun B, Liu YJ. Human NLRP3 infl ammasome senses multiple types of bacterial RNAs. Proc Natl Acad Sci U S A 2014;111(45):16059–16064.

284. Shigeyasu K, Tanakaya K, Nagasaka T, Aoki H, Fujiwara T, Sugano K, Ishikawa H, Yoshida T, Moriya Y, Furukawa Y, Goel A, Takeuchi H. Early detection of metachronous bile duct cancer in Lynch syndrome: report of a case. Surg Today 2014;44(10):1975–1981.

285. Sivendran S, Chang R, Pham L, Phelps RG, Harcharik ST, Hall LD, Bernardo SG, Moskalenko MM, Sivendran M, Fu Y, de Moll EH, Pan M, Moon JY, Arora S, Cohain A, DiFeo A, Ferringer TC, Tismenetsky

M, Tsui CL, Friedlander PA, Parides MK, Banchereau J, Chaussabel D, Lebwohl MG, Wolchok JD, Bhardwaj N, Burakoff SJ, Oh WK, Palucka K, Merad M, Schadt EE, Saenger YM. Dissection of immune gene networks in primary melanoma tumors critical for antitumor sur-veillance of patients with stage II-III resectable disease. J Invest Dermatol 2014;134(8):2202–2211.

286. Skinner JA, Zurawski SM, Sugimoto C, Vinet-Oliphant H, Vinod P, Xue Y, Russell-Lodrigue K, Albrecht RA, García-Sastre A, Salazar AM, Roy CJ, Kuroda MJ, Oh S, Zurawski G. Immunologic characterization of a rhesus macaque H1N1 challenge model for candidate infl uenza virus vaccine assessment. Clin Vaccine Immunol 2014;21(12):1668–1680.

287. Sugimoto N, Mitoma H, Kim T, Hanabuchi S, Liu YJ. Helicase proteins DHX29 and RIG-I cosense cytosolic nucleic acids in the human airway system. Proc Natl Acad Sci U S A 2014;111(21):7747–7752.

288. Toden S, Goel A. Th e importance of diets and epigenetics in cancer prevention: a hope and promise for the future? Altern Th er Health Med 2014;20(Suppl 2):6–11.

289. Tsang JS, Schwartzberg PL, Kotliarov Y, Biancotto A, Xie Z, Germain RN, Wang E, Olnes MJ, Narayanan M, Golding H, Moir S, Dickler HB, Perl S, Cheung F; Baylor HIPC Center; CHI Consortium. Global analyses of human immune variation reveal baseline predictors of post-vaccination responses. Cell 2014;157(2):499–513.

290. Wang S, Qin L, Wu T, Deng B, Sun Y, Hu D, Mohan C, Zhou XJ, Peng A. Elevated cardiac markers in chronic kidney disease as a consequence of hyperphosphatemia-induced cardiac myocyte injury. Med Sci Monit 2014;20:2043–2053.

291. Weng L, Mitoma H, Trichot C, Bao M, Liu Y, Zhang Z, Liu YJ. Th e E3 ubiquitin ligase tripartite motif 33 is essential for cytosolic RNA-induced NLRP3 infl ammasome activation. J Immunol 2014;193(7):3676–3682.

292. Wu TC, Xu K, Banchereau R, Marches F, Yu CI, Martinek J, Anguiano E, Pedroza-Gonzalez A, Snipes GJ, O’Shaughnessy J, Nishimura S, Liu YJ, Pascual V, Banchereau J, Oh S, Palucka K. Reprogram-ming tumor-infi ltrating dendritic cells for CD103+ CD8+ mucosal T-cell diff erentiation and breast cancer rejection. Cancer Immunol Res 2014;2(5):487–500.

293. Xu W, Narayanan P, Kang N, Clayton S, Ohne Y, Shi P, Herve MC, Balderas R, Picard C, Casanova JL, Gorvel JP, Oh S, Pascual V, Banchereau J. Human plasma cells express granzyme B. Eur J Immunol 2014;44(1):275–284.

294. You X, Huang P, Zhang C, Wang M, Zhang Y, Hong Y, Wei S, Liu C, Pu Z, Zhang J, Chen S. Relationship between enhanced intensity of contrast enhanced ultrasound and microvessel density of aortic atherosclerostic plaque in rabbit model. PLoS One 2014;9(4):e92445.

295. Yu CI, Becker C, Metang P, Marches F, Wang Y, Toshiyuki H, Banchereau J, Merad M, Palucka AK. Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines. J Immunol 2014;193(9):4335–4343.

296. Zhang C, Huang P, Zhang Y, Chen J, Shentu W, Sun Y, Yang Z, Chen S. Anti-tumor effi cacy of ultrasonic cavitation is potentiated by con-current delivery of anti-angiogenic drug in colon cancer. Cancer Lett 2014;347(1):105–113.

297. Zhang Y, Macaubas C, Gupta S, Klein C, Pascual V, Hay A, Th ompson SD, Sandborg CI, Ilowite NT, Mellins ED. Role of interleukin-1 in abnormal monocyte phenotype in systemic onset juvenile idiopathic arthritis. Arthritis Rheumatol 2014;66(Suppl S3):S207–S208.

298. Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, Stone DL, Chae JJ, Rosenzweig SD, Bishop K, Barron KS, Kuehn HS, Hoff mann P, Negro A, Tsai WL, Cowen EW, Pei W, Milner JD, Silvin C, Heller T, Chin DT, Patronas NJ, Barber JS, Lee CC, Wood GM, Ling A, Kelly SJ, Kleiner DE, Mullikin JC, Ganson NJ, Kong HH, Hambleton S, Candotti F, Quezado MM, Calvo KR, Alao H, Barham BK, Jones A, Meschia JF, Worrall BB, Kasner SE, Rich SS, Goldbach-Mansky R, Abinun M, Chalom E, Gotte AC, Punaro M, Pascual V, Verbsky JW, Torgerson TR, Singer NG, Gershon TR, Ozen S, Karadag O, Fleisher TA, Remmers EF, Burgess SM, Moir SL, Gadina M, Sood R, Hershfi eld MS, Boehm M, Kastner DL, Aksentijevich I. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med 2014;370(10):911–920.


275

INFECTIOUS DISEASES299. Campa-Th ompson MM, West JA, Guileyardo JM, Spak CW, Sloan LM,

Beal SG. Clinical and morphologic fi ndings in disseminated Scedosporium apiospermum infections in immunocompromised patients. Proc (Bayl Univ Med Cent) 2014;27(3):253–256.

300. Hocevar SN, Paddock CD, Spak CW, Rosenblatt R, Diaz-Luna H, Castillo I, Luna S, Friedman GC, Antony S, Stoddard RA, Tiller RV, Peterson T, Blau DM, Sriram RR, da Silva A, de Almeida M, Benedict T, Goldsmith CS, Zaki SR, Visvesvara GS, Kuehnert MJ; Microsporidia Transplant Transmission Investigation Team. Microsporidiosis acquired through solid organ transplantation: a public health investigation. Ann Intern Med 2014;160(4):213–220.

301. Jennings A, Bennett M, Fisher T, Cook A. Impact of a surveillance screening program on rates of methicillin-resistant Staphylococcus aureus infections with a comparison of surgical versus nonsurgical patients. Proc (Bayl Univ Med Cent) 2014;27(2):83–87.

302. Skaug M, Spak C, Oza U. Painful periostitis in the setting of chronic voriconazole therapy. Proc (Bayl Univ Med Cent) 2014;27(4):350–352.

INTERNAL MEDICINE AND FAMILY MEDICINENote: Most family medicine and internal medicine articles are subclassifi ed by specialty, even if generalists were fi rst authors or coauthors.303. Holder SD, Wayhs A. Schizophrenia. Am Fam Physician 2014;90(11):

775–82.304. Narla R, Peck SB, Qiu KM. FPIN’s clinical inquiries. Fish oil for treat-

ment of dyslipidemia. Am Fam Physician 2014;89(4):288, 290.305. Peck SB, Gilchrist J, Clemans-Taylor L. Clinical inquiry: is there a pri-

mary care tool to detect aberrant drug-related behaviors in patients on opioids? J Fam Pract 2014;63(3):162–164.

306. Snyder RJ, Frykberg RG, Rogers LC, Applewhite AJ, Bell D, Bohn G, Fife CE, Jensen J, Wilcox J. Th e management of diabetic foot ulcers through optimal off -loading: building consensus guidelines and practi-cal recommendations to improve outcomes. J Am Podiatr Med Assoc 2014;104(6):555–567.

307. Yates SW. Interrupting anticoagulation in patients with nonvalvular atrial fi brillation. P T 2014;39(12):858–880.

METABOLIC DISEASES308. Arning E, Bottiglieri T. LC-MS/MS Analysis of cerebrospinal fl uid

metabolites in the pterin biosynthetic pathway. JIMD Rep 2014 Sep 12 [Epub ahead of print].

309. Chen CC, Keller M, Hess M, Schiff mann R, Urban N, Wolfgardt A, Schaefer M, Bracher F, Biel M, Wahl-Schott C, Grimm C. A small molecule restores function to TRPML1 mutant isoforms responsible for mucolipidosis type IV. Nat Commun 2014;5:4681.

310. Dallabona C, Diodato D, Kevelam SH, Haack TB, Wong LJ, Salomons GS, Baruffi ni E, Melchionda L, Mariotti C, Strom TM, Meitinger T, Prokisch H, Chapman K, Colley A, Rocha H, Ounap K, Schiff mann R, Salsano E, Savoiardo M, Hamilton EM, Abbink TE, Wolf NI, Ferrero I, Lamperti C, Zeviani M, Vanderver A, Ghezzi D, van der Knaap MS. Novel (ovario) leuko-dystrophy related to AARS2 mutations. Neurology 2014;82(23):2063–2071.

311. Dayal S, Blokhin IO, Erger RA, Jensen M, Arning E, Stevens JW, Bottiglieri T, Faraci FM, Lentz SR. Protective vascular and cardiac eff ects of inducible nitric oxide synthase in mice with hyperhomocysteinemia. PLoS One 2014;9(9):e107734.

312. Fang P, Zhang D, Cheng Z, Yan C, Jiang X, Kruger WD, Meng S, Arning E, Bottiglieri T, Choi ET, Han Y, Yang XF, Wang H. Hyperhomocys-teinemia potentiates hyperglycemia-induced infl ammatory monocyte diff erentiation and atherosclerosis. Diabetes 2014;63(12):4275–4290.

313. Gerbarg PL, Muskin PR, Bottiglieri T, Brown RP. Failed studies should not be used to malign good treatments. J Clin Psychiatry 2014;75(11):e1328.

314. Hamilton EM, Polder E, Vanderver A, Naidu S, Schiff mann R, Fisher K, Raguž AB, Blumkin L; H-ABC Research Group, van Berkel CG, Waisfi sz Q, Simons C, Taft RJ, Abbink TE, Wolf NI, van der Knaap MS. Hypomyelination with atrophy of the basal ganglia and cerebellum: further delineation of the phenotype and genotype-phenotype correla-tion. Brain 2014;137(Pt 7):1921–1930.

315. Harding CO, Winn SR, Gibson KM, Arning E, Bottiglieri T, Grompe M. Pharmacologic inhibition of L-tyrosine degradation ameliorates cerebral dopamine defi ciency in murine phenylketonuria (PKU). J Inherit Metab Dis 2014;37(5):735–743.

316. Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK, Baker M, Ballow M, Bartoshesky LE, Bonilla FA, Brokopp C, Brooks E, Caggana M, Celestin J, Church JA, Comeau AM, Connelly JA, Cowan MJ, Cunningham-Rundles C, Dasu T, Dave N, De La Morena MT, Duff ner U, Fong CT, Forbes L, Freedenberg D, Gelfand EW, Hale JE, Hanson IC, Hay BN, Hu D, Infante A, Johnson D, Kapoor N, Kay DM, Kohn DB, Lee R, Lehman H, Lin Z, Lorey F, Abdel-Mageed A, Manning A, McGhee S, Moore TB, Naides SJ, Notarangelo LD, Orange JS, Pai SY, Porteus M, Rodriguez R, Romberg N, Routes J, Ruehle M, Rubenstein A, Saavedra-Matiz CA, Scott G, Scott PM, Secord E, Seroogy C, Shearer WT, Siegel S, Silvers SK, Stiehm ER, Sugerman RW, Sullivan JL, Tanksley S, Tierce ML 4th, Verbsky J, Vogel B, Walker R, Walkovich K, Walter JE, Wasserman RL, Watson MS, Weinberg GA, Weiner LB, Wood H, Yates AB, Puck JM, Bonagura VR. Newborn screening for severe combined immunodefi ciency in 11 screening programs in the United States. JAMA 2014;312(7):729–738.

317. Papakostas GI, Shelton RC, Zajecka JM, Bottiglieri T, Roff man J, Cassi-ello C, Stahl SM, Fava M. Eff ect of adjunctive L-methylfolate 15 mg among inadequate responders to SSRIs in depressed patients who were stratifi ed by biomarker levels and genotype: results from a randomized clinical trial. J Clin Psychiatry 2014;75(8):855–863.

318. Parikh S, Bernard G, Leventer RJ, van der Knaap MS, van Hove J, Pizzino A, McNeill NH, Helman G, Simons C, Schmidt JL, Rizzo WB, Patterson MC, Taft RJ, Vanderver A; on behalf of the GLIA Consortium. A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies. Mol Genet Metab 2014 Dec 29 [Epub ahead of print].

319. Pfalzer AC, Choi SW, Tammen SA, Park LK, Bottiglieri T, Parnell LD, Lamon-Fava S. S-adenosylmethionine mediates inhibition of infl amma-tory response and changes in DNA methylation in human macrophages. Physiol Genomics 2014;46(17):617–623.

320. Pizzino A, Pierson TM, Guo Y, Helman G, Fortini S, Guerrero K, Saitta S, Patrick Murphy JL, Padiath Q, Xie Y, Hakonarson H, Xu X, Funari T, Fox M, Taft RJ, van der Knaap MS, Bernard G, Schiff mann R, Simons C, Vanderver A. TUBB4A de novo mutations cause isolated hypomy-elination. Neurology 2014;83(10):898–902.

321. Schiff mann R, Forni S, Swift C, Brignol N, Wu X, Lockhart DJ, Blankenship D, Wang X, Grayburn PA, Taylor MR, Lowes BD, Fuller M, Benjamin ER, Sweetman L. Risk of death in heart disease is associated with elevated urinary globotriaosylceramide. J Am Heart Assoc 2014;3(1):e000394.

322. Schiff mann R, Mayfi eld J, Swift C, Nestrasil I. Quantitative neuroimag-ing in mucolipidosis type IV. Mol Genet Metab 2014;111(2):147–151.

323. Schiff mann R, Pastores GM, Lien YHH, Castaneda V, Chang P, Martin R, Wijatyk A. Agalsidase alfa in pediatric patients with Fabry disease: a 6.5-year open-label follow-up study. Orphanet J Rare Dis 2014;9(1):169.

324. Sontag JM, Wasek B, Taleski G, Smith J, Arning E, Sontag E, Bottiglieri T. Altered protein phosphatase 2A methylation and Tau phosphorylation in the young and aged brain of methylenetetrahydrofolate reductase (MTHFR) defi cient mice. Front Aging Neurosci 2014;6:214.

325. Vanderver A, Tonduti D, Schiff mann R, Schmidt J, Van der Knaap MS. Leukodystrophy overview. In Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, eds. SourceGeneReviews™ [Internet]. Seattle, WA: University of Washington, Seattle, 2014. Available at http://www.ncbi.nlm.nih.gov/books/NBK184570/.

326. Vogel KR, Arning E, Wasek BL, McPherson S, Bottiglieri T, Gibson KM. Brain-blood amino acid correlates following protein restriction in murine maple syrup urine disease. Orphanet J Rare Dis 2014;9:73.

327. Wolf NI, Vanderver A, van Spaendonk RM, Schiff mann R, Brais B, Bugiani M, Sistermans E, Catsman-Berrevoets C, Kros JM, Pinto PS, Pohl D, Tirupathi S, Strømme P, de Grauw T, Fribourg S, Demos M, Pizzino A, Naidu S, Guerrero K, van der Knaap MS, Bernard G; 4H Research Group. Clinical spectrum of 4H leukodystrophy caused by POLR3A and POLR3B mutations. Neurology 2014;83(21):1898–1905.


276276

328. Yano S, Moseley K, Bottiglieri T, Arning E, Azen C. Maternal Phe-nylketonuria International Collaborative Study revisited: evaluation of maternal nutritional risk factors besides phenylalanine for fetal congenital heart defects. J Inherit Metab Dis 2014;37(1):39–42.

NEPHROLOGY329. Afzal A, Collazo R, Fenves AZ, Schwartz J. Methemoglobinemia

precipitated by benzocaine used during intubation. Proc (Bayl Univ Med Cent) 2014;27(2):133–135.

330. Akrawinthawong K, Ricci J, Cannon L, Dixon S, Kupfer K, Stivers D, Alexander P, David S, McCullough PA. Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for deter-mining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study. Ren Fail 2014;18:1–5.

331. Allam SR, Livingston TS, Kalaria V, Diaz-Calderon W, Pumphrey JA, Patel L, Sankarapandian B. Posterior nutcracker syndrome: an infrequent cause of hematuria. Kidney Int 2014;85(4):985–986.

332. Brown JR, Solomon RJ, Sarnak MJ, McCullough PA, Splaine ME, Davies L, Ross CS, Dauerman HL, Stender JL, Conley SM, Robb JF, Chaisson K, Boss R, Lambert P, Goldberg DJ, Lucier D, Fedele FA, Kellett MA, Horton S, Phillips WJ, Downs C, Wiseman A, MacKenzie TA, Malenka DJ; Northern New England Cardiovascular Disease Study Group. Reducing contrast-induced acute kidney injury using a regional multicenter quality im-provement intervention. Circ Cardiovasc Qual Outcomes 2014;7(5):693–700.

333. Emmett M. Acetaminophen toxicity and 5-oxoproline (pyroglutamic acid): a tale of two cycles, one an ATP-depleting futile cycle and the other a useful cycle. Clin J Am Soc Nephrol 2014;9(1):191–200.

334. Emmett M. Albuminuria. Cleve Clin J Med 2014;81(6):345. 335. Hoste EA, McCullough PA, Kashani K, Chawla LS, Joannidis M, Shaw

AD, Feldkamp T, Uettwiller-Geiger DL, McCarthy P, Shi J, Walker MG, Kellum JA; Sapphire Investigators. Derivation and validation of cutoff s for clinical use of cell cycle arrest biomarkers. Nephrol Dial Transplant 2014;29(11):2054–2061.

336. Maioli M, Toso A, Leoncini M, Musilli N, Bellandi F, Rosner MH, McCullough PA, Ronco C. Pre-procedural bioimpedance vectorial analy-sis of fl uid status and prediction of contrast-induced acute kidney injury. J Am Coll Cardiol 2014;63(14):1387–1394.

337. McCullough PA, Whaley-Connell AT, Vassalotti JA. Th e future of CKD detection: the role for the kidney early evaluation program. Nephrol News Issues 2014;28(4):41–42.

338. Roberts JK, McCullough PA. Th e management of acute coronary syn-dromes in patients with chronic kidney disease. Adv Chronic Kidney Dis 2014;21(6):472–479.

339. Shah R, Shah N, Shah A, Mehta AN. Steroid-resistant nephrotic syn-drome secondary to primary focal segmental glomerulosclerosis and smol-dering multiple myeloma. Proc (Bayl Univ Med Cent) 2014;27(1):19–21.

340. Szczech LA, Stewart RC, Su HL, DeLoskey RJ, Astor BC, Fox CH, McCullough PA, Vassalotti JA. Primary care detection of chronic kidney disease in adults with type-2 diabetes: the ADD-CKD Study (awareness, detection and drug therapy in type 2 diabetes and chronic kidney disease). PLoS One 2014;9(11):e110535.

341. Tan V, Schwartz JC. Renal failure due to Capnocytophaga canimorsus generalized Shwartzman reaction from a dog bite (DF-2 nephropathy). Proc (Bayl Univ Med Cent) 2014;27(2):139–140.

342. Tan V, Schwartz JC. Where is that hemodialysis catheter (superior vena cava or aorta)? A case of intraarterial catheter placement. Proc (Bayl Univ Med Cent) 2014;27(2):136–138.

343. Zimering MB, Zhang JH, Guarino PD, Emanuele N, McCullough PA, Fried LF; Investigators for the VA NEPHRON-D. Endothelial cell autoantibodies in predicting declining renal function, end-stage renal disease, or death in adult type 2 diabetic nephropathy. Front Endocrinol (Lausanne) 2014;5:128.

NEUROLOGY/NEUROSURGERY/SPINAL SURGERY344. Acosta FL Jr, Ames C, Hsieh PC, McCarthy IM. Introduction:

Costs and benefits of modern-day spine care. Neurosurg Focus 2014;36(6): Introduction.

345. Afzal A, Ashraf S, Shamim S. Opsoclonus myoclonus syndrome: an unusual presentation for West Nile virus encephalitis. Proc (Bayl Univ Med Cent) 2014;27(2):108–110.

346. Benjamin MM, Martin AW, Rosenblatt RL. Bilateral diaphragmatic paralysis associated with the use of the tumor necrosis factor-alpha in-hibitor adalimumab. Proc (Bayl Univ Med Cent) 2014;27(2):113–115.

347. Bess S, Line BG, Lafage V, Schwab F, Shaff rey CI, Hart RA, Boachie-Adjei O, Akbarnia BA, Ames CP, Burton DC, Deverin V, Fu KM, Gupta M, Hostin R, Kebaish K, Klineberg E, Mundis G, O’Brien M, Shelokov A, Smith JS; International Spine Study Group ISSG. Does recombinant human bone morphogenetic protein-2 use in adult spinal deformity increase complications and are complications associated with location of rhBMP-2 use? A prospective, multicenter study of 279 consecutive patients. Spine (Phila Pa 1976) 2014;39(3):233–242.

348. Bianco K, Norton R, Schwab F, Smith JS, Klineberg E, Obeid I, Mundis G Jr, Shaff rey CI, Kebaish K, Hostin R, Hart R, Gupta MC, Burton D, Ames C, Boachie-Adjei O, Protopsaltis TS, Lafage V; International Spine Study Group. Complications and intercenter variability of three-column osteotomies for spinal deformity surgery: a retrospective review of 423 patients. Neurosurg Focus 2014;36(5):E18.

349. Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, Montgomery J, Nizam A, Lane BF, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Lynch JR, Zaidat OO, Rumboldt Z, Cloft HJ; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the fi nal results of a randomised trial. Lancet 2014;383(9914):333–341.

350. Fox RJ, Kita M, Cohan SL, Henson LJ, Zambrano J, Scannevin RH, O’Gorman J, Novas M, Dawson KT, Phillips JT. BG-12 (dimethyl fumarate): a review of mechanism of action, effi cacy, and safety. Curr Med Res Opin 2014;30(2):251–262.

351. Fu KM, Bess S, Shaff rey CI, Smith JS, Lafage V, Schwab F, Burton DC, Akbarnia BA, Ames CP, Boachie-Adjei O, Deverin V, Hart RA, Hostin R, Klineberg E, Gupta M, Kebaish K, Mundis G, Mummaneni PV; International Spine Study Group. Patients with adult spinal deformity treated operatively report greater baseline pain and disability than patients treated nonoperatively; however, deformities diff er between age groups. Spine (Phila Pa 1976) 2014;39(17):1401–1407.

352. Fu KM, Smith JS, Burton DC, Kebaish KM, Shaff rey CI, Schwab F, Lafage V, Arlet V, Hostin R, Boachie O, Akbarnia B, Bess S; Interna-tional Spine Study Group. Revision extension to the pelvis versus primary spinopelvic instrumentation in adult deformity: comparison of clinical outcomes and complications. World Neurosurg 2014;82(3–4):e547–e552.

353. Gold R, Giovannoni G, Phillips JT, Fox RJ, Zhang A, Meltzer L, Kuru-kulasuriya NC. Effi cacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing-remitting multiple sclerosis (RRMS). Mult Scler 2014 Jul 2 [Epub ahead of print].

354. Gov V, McCarthy I, Dallas K, Weinreb JJ, Bendo JA, Lafage V, Errico T. Venous thromboembolic events in spine surgery patients: which patients are high risk? J Bone Joint Surg Am 2014;96(11):936–942.

355. Kim HJ, Boachie-Adjei O, Shaff rey CI, Schwab F, Lafage V, Bess S, Gupta MC, Smith JS, Deviren V, Akbarnia B, Mundis GM, O’Brien M, Hostin R, Ames C; International Spine Study Group. Upper tho-racic versus lower thoracic upper instrumented vertebrae endpoints have similar outcomes and complications in adult scoliosis. Spine (Phila Pa 1976) 2014;39(13):E795–E799.

356. Kita M, Fox RJ, Gold R, Giovannoni G, Phillips JT, Sarda SP, Kong J, Viglietta V, Sheikh SI, Okwuokenye M, Kappos L. Eff ects of delayed-release dimethyl fumarate (DMF) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: an integrated analysis of the phase 3 DEFINE and CONFIRM studies. Clin Th er 2014;36(12):1958–1971.

357. Liu S, Schwab F, Smith JS, Klineberg E, Ames CP, Mundis G, Hostin R, Kebaish K, Deviren V, Gupta M, Boachie-Adjei O, Hart RA, Bess S,


277

Lafage V. Likelihood of reaching minimal clinically important diff erence in adult spinal deformity: a comparison of operative and nonoperative treatment. Ochsner J 2014;14(1):67–77.

358. Maier S, Smith JS, Schwab F, Obeid I, Mundis G, Klineberg E, Hostin R, Hart R, Burton D, Boachie-Adjei O, Gupta M, Ames C, Protopsaltis T, Lafage V, International Spine Study Group. Revision surgery after three-column osteotomy in 335 adult spinal deformity patients: inter-center variability and risk factors. Spine (Phila Pa 1976) 2014 Feb 27 [Epub ahead of print].

359. McCarthy I, O’Brien M, Ames C, Robinson C, Errico T, Polly DW Jr, Hostin R; International Spine Study Group. Incremental cost-eff ective-ness of adult spinal deformity surgery: observed quality-adjusted life years with surgery compared with predicted quality-adjusted life years without surgery. Neurosurg Focus 2014;36(5):E3.

360. McCarthy I, Robinson CB, O’Brien MF, Hostin RA. Total costs of multi-level fusion surgery including outpatient care. SpineLine 2014;15(3):21–24.

361. McCarthy IM, Hostin RA, Ames CP, Kim HJ, Smith JS, Boachie-Adjei O, Schwab FJ, Klineberg EO, Shaff rey CI, Gupta MC, Polly DW; In-ternational Spine Study Group. Total hospital costs of surgical treat-ment for adult spinal deformity: an extended follow-up study. Spine J 2014;14(10):2326–2333.

362. Mitsumoto H, Factor-Litvak P, Andrews H, Goetz RR, Andrews L, Rabkin JG, McElhiney M, Nieves J, Santella RM, Murphy J, Hupf J, Singleton J, Merle D, Kilty M, Heitzman D, Bedlack RS, Miller RG, Katz JS, Forshew D, Barohn RJ, Sorenson EJ, Oskarsson B, Fernandes Filho JA, Kasarskis EJ, Lomen-Hoerth C, Mozaff ar T, Rollins YD, Nations SP, Swenson AJ, Shefner JM, Andrews JA, Koczon-Jaremko BA; ALS COSMOS Study Group. ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and base-line demographic and disease characteristics. Amyotroph Lateral Scler Frontotemporal Degener 2014;15(3–4):192–203.

363. Protopsaltis T, Schwab F, Bronsard N, Smith JS, Klineberg E, Mundis G, Ryan DJ, Hostin R, Hart R, Burton D, Ames C, Shaff rey C, Bess S, Errico T, Lafage V; International Spine Study Group. Th e T1 pelvic angle, a novel radiographic measure of global sagittal deformity, accounts for both spinal inclination and pelvic tilt and correlates with health-related quality of life. J Bone Joint Surg Am 2014;96(19):1631–1640.

364. Rabkin J, Ogino M, Goetz R, McElhiney M, Hupf J, Heitzman D, Heiman-Patterson T, Miller R, Katz J, Lomen-Hoerth C, Imai T, Atsuta N, Morita M, Tateishi T, Matsumura T, Mitsumoto H. Japanese and American ALS patient preferences regarding TIV (tracheostomy with invasive ventilation): a cross-national survey. Amyotroph Lateral Scler Frontotemporal Degener 2014;15(3–4):185–191.

365. Ryan DJ, Protopsaltis TS, Ames CP, Hostin R, Klineberg E, Mundis GM, Obeid I, Kebaish K, Smith JS, Boachie-Adjei O, Burton DC, Hart RA, Gupta M, Schwab FJ, Lafage V; International Spine Study Group. T1 pelvic angle (TPA) eff ectively evaluates sagittal deformity and assesses radiographical surgical outcomes longitudinally. Spine (Phila Pa 1976) 2014;39(15):1203–1210.

366. Saad AF, Layton KF, Finn SS, Opatowsky MJ. Ganglioglioma and mi-graine headache. Proc (Bayl Univ Med Cent) 2014;27(3):215–216.

367. Saad AF, Nickell LT, Finn SS, Opatowsky MJ. Spinal cord ependymoma presenting with neurological defi cits in the setting of trauma. Proc (Bayl Univ Med Cent) 2014;27(3):213–214.

368. Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, Rymer MM, Th ijs V, Rogers T, Beckers F, Lindborg K, Brachmann J; CRYSTAL AF Investigators. Cryptogenic stroke and underlying atrial fi brillation. N Engl J Med 2014;370(26):2478–2486.

369. Scheer JK, Lafage V, Smith JS, Deviren V, Hostin R, McCarthy IM, Mundis GM, Burton DC, Klineberg E, Gupta MC, Kebaish KM, Shaff rey CI, Bess S, Schwab F, Ames CP; International Spine Study Group. Impact of age on the likelihood of reaching a minimum clinically important diff erence in 374 three-column spinal osteotomies. J Neurosurg Spine 2014;20(3):306–312.

370. Scheer JK, Lafage V, Smith JS, Deviren V, Hostin R, McCarthy IM, Mundis GM, Burton DC, Klineberg E, Gupta M, Kebaish K, Shaff rey CI, Bess S, Schwab F, Ames CP; International Spine Study Group (ISSG).

Maintenance of radiographic correction at 2 years following lumbar pedicle subtraction osteotomy is superior with upper thoracic compared with thoracolumbar junction upper instrumented vertebra. Eur Spine J 2014 Jun 1 [Epub ahead of print].

371. Slobodyanyuk K, Poorman CE, Smith JS, Protopsaltis TS, Hostin R, Bess S, Mundis GM Jr, Schwab FJ, Lafage V; International Spine Study Group. Clinical improvement through nonoperative treatment of adult spinal deformity: who is likely to benefi t? Neurosurg Focus 2014;36(5):E2.

372. Smith JS, Lafage V, Schwab FJ, Shaff rey CI, Protopsaltis T, Klineberg E, Gupta M, Scheer JK, Fu KM, Mundis G, Hostin R, Deviren V, Hart R, Burton DC, Bess S, Ames CP; International Spine Study Group. Prevalence and type of cervical deformity among 470 adults with thora-columbar deformity. Spine (Phila Pa 1976) 2014;39(17):E1001–E1009.

373. Smith JS, Shaff rey E, Klineberg E, Shaff rey CI, Lafage V, Schwab FJ, Protopsaltis T, Scheer JK, Mundis GM Jr, Fu KM, Gupta MC, Hostin R, Deviren V, Kebaish K, Hart R, Burton DC, Line B, Bess S, Ames CP; International Spine Study Group. Prospective multicenter assessment of risk factors for rod fracture following surgery for adult spinal deformity. J Neurosurg Spine 2014;21(6):994–1003.

374. Smith JS, Singh M, Klineberg E, Shaff rey CI, Lafage V, Schwab FJ, Protopsaltis T, Ibrahimi D, Scheer JK, Mundis G Jr, Gupta MC, Hostin R, Deviren V, Kebaish K, Hart R, Burton DC, Bess S, Ames CP; Inter-national Spine Study Group. Surgical treatment of pathological loss of lumbar lordosis (fl atback) in patients with normal sagittal vertical axis achieves similar clinical improvement as surgical treatment of elevated sagittal vertical axis: clinical article. J Neurosurg Spine 2014;21(2):160–170.

NURSING/ALLIED HEALTH375. Allen D, Leeper B. Overview of extracorporeal membrane oxygenation in

cardiogenic shock. Crit Care Nurs Clin North Am 2014;26(4):581–588. 376. Beseda R, Smith S, Veenstra A. Th erapeutic hypothermia after cardiac

arrest and return of spontaneous circulation: it’s complicated. Crit Care Nurs Clin North Am 2014;26(4):511–524.

377. Brantley SL, Russell MK, Mogensen KM, Wooley JA, Bobo E, Chen Y, Malone A, Roberts S, Romano MM, Taylor B. American Society for Parenteral and Enteral Nutrition and Academy of Nutrition and Di-etetics: revised 2014 standards of practice and standards of professional performance for registered dietitian nutritionists (competent, profi cient, and expert) in nutrition support. Nutr Clin Pract 2014;29(6):792–828.

378. Centeno MM, Kahveci KL. Transitional care models: preventing readmis-sions for high-risk patient populations. Crit Care Nurs Clin North Am 2014 Dec;26(4):589–597.

379. Dickerson PS, Chappell K, Decker S, Moore D, Pilcher J, Scanlon N, Hons B, Sherman L. Developing an interprofessional continuing educa-tion symposium for health care educators in Qatar. J Contin Ed Nurs 2014;45(12):545–551.

380. Ellis A. In regard to ‘Nurse manager succession planning: synthesis of evidence’. J Nurs Manag 2014;22(3):405.

381. Flanders S, Zwerneman K. Pulmonary embolism: prevention, recogni-tion, and treatment. Nursing 2014 Critical Care, 9(6):14-20.

382. Flanders SA, Strasen JH. Review of evidence about family presence during resuscitation. Crit Care Nurs Clin North Am 2014;26(4):533–550.

383. Foster J, Flanders S. Challenges in CNS practice and education. Online J Issues Nurs 2014;19(2):1.

384. Gunn S, Fowler RJ. Back to basics: importance of nursing interven-tions in the elderly critical care patient. Crit Care Nurs Clin North Am 2014;26(4):433–446.

385. Hasse JM. Early postoperative tube feeding in liver transplantation. Nutr Clin Pract 2014;29(2):222–228.

386. Huddleston P, Zimmermann MB. Stroke care using a hub and spoke model with telemedicine. Crit Care Nurs Clin North Am 2014;26(4):469–475.

387. Leeper B, Luquire R. Quality. Crit Care Nurs Clin North Am 2014;26(4):xiii–xv.

388. Morehead D, Blain B. Driving hospital-acquired pressure ulcers to zero. Crit Care Nurs Clin North Am 2014;26(4):559–567.


278278

389. Nuss T, Kelly KM, Campbell KR, Pierce C, Entzminger JK, Blair BK, Wissinger L, Bryant L, Walker JL. Th e impact of opening visitation access on patient and family experience. J Nurs Adm 2014;44(7/8):403–410.

390. Pilcher J, Flanders S. Who is Billy Reuben? Health literacy and patient education. Neonatal Netw 2014;33(3):150–154.

391. Pilcher J. Education and learning: what’s on the horizon? Neonatal Netw 2014;33(1):24–28.

392. Pilcher J. Problem-based learning in the NICU. Neonatal Netw 2014;33(4):221–224.

393. Powell KK, Fowler RJ. Driving sepsis mortality down: emergency de-partment and critical care partnerships. Crit Care Nurs Clin North Am 2014;26(4):487–498.

394. Restau J, Green P. Palliative care in the intensive care unit. Crit Care Nurs Clin North Am 2014;26(4):551–558.

395. Schlein KM, Coulter SP. Best practices for determining resting energy expenditure in critically ill adults. Nutr Clin Pract 2014;29(1):44–55.

396. Shuey KM, Balch C. Fall prevention in high-risk patients. Crit Care Nurs Clin North Am 2014;26(4):569–580.

397. Smith LE, Flanders SA. Application of a comprehensive unit-based safety program in critical care: the royal exchange. Crit Care Nurs Clin North Am 2014;26(4):447–460.

398. South T, Adair B. Open access in the critical care environment. Crit Care Nurs Clin North Am 2014;26(4):525–532.

399. Sundin CS. Peripartum cardiomyopathy. MCN Am J Matern Child Nurs 2014;39(4):220–224.

400. Veenstra A, Untalan E. Implications and interventions related to obstruc-tive sleep apnea. Crit Care Nurs Clin North Am 2014;26(4):499–509.

401. Wheeler M, Crenshaw C, Gunn S. Incidence and prevention of delirium in critical care patients. Crit Care Nurs Clin North Am 2014;26(4):461–468.

402. White A. Outpatient interventions for hepatology patients with fl uid retention: a review and synthesis of the literature. Gastroenterol Nurs 2014;37(3):236–244.

403. Xiao Y, Montgomery DC, Philpot LM, Barnes SA, Compton J, Kennerly D. Development of a tool to measure user experience following electronic health record implementation. J Nurs Adm 2014;44(7/8):423–428.

OBSTETRICS/GYNECOLOGY/FETAL MEDICINE404. Bekhit M, Jackson T, Advincula AP. Simulation study comparing the

eff ectiveness of the Gynecare Morcellex®, the MOREsolution™, and the Rotocut™ G1 tissue Morcellators. Surg Technol Int 2014;24:237–22.

405. Ehsanipoor RM, Jolley JA, Goldshore MA, Szymanski LM, Haydon ML, Gaff aney CL, Lagrew DC. Th e relationship between previous treatment for cervical dysplasia and preterm delivery in twin gestations. J Matern Fetal Neonatal Med 2014;27(8):821–824.

406. Gidvani MP, Th eisen E, Leduc R, George CL. Maternal surfactant protein A infl uences the immunoprotective properties of milk in a murine model. Pediatr Res 2014;76(2):135–141.

407. Nelson DB, Yost NP, Cunningham FG. Hemostatic dysfunction with acute fatty liver of pregnancy. Obstet Gynecol 2014;124(1):40–46.

ONCOLOGY/HEMATOLOGY/SURGICAL ONCOLOGY/BONE MARROW TRANSPLANTATION408. Aapro M, Moebus V, Nitz U, O’Shaughnessy J, Pronzato P, Untch M,

Tomita D, Bohac C, Leyland-Jones B. Safety and effi cacy outcomes with erythropoiesis-stimulating agents in patients with breast cancer: a meta-analysis. Ann Oncol 2014 Dec 26 [Epub ahead of print].

409. Abbas MA, Chang GJ, Read TE, Rothenberger DA, Garcia-Aguilar J, Peters W, Monson JR, Sharma A, Dietz DW, Madoff RD, Fleshman JW, Greene FL, Wexner SD, Remzi FH; Consortium for Optimizing Surgi-cal Treatment of Rectal Cancer. Optimizing rectal cancer management: analysis of current evidence. Dis Colon Rectum 2014;57(2):252–259.

410. Becerra CR, Conkling P, Vogelzang N, Wu H, Hong S, Narwal R, Liang M, Tavakkoli F, Pandya N. A phase I dose-escalation study of MEDI-575, a PDGFRα monoclonal antibody, in adults with advanced solid tumors. Cancer Chemother Pharmacol 2014;74(5):917–925.

411. Becerra CR, Salazar R, Garcia-Carbonero R, Th omas AL, Vázquez-Mazón FJ, Cassidy J, Maughan T, Castillo MG, Iveson T, Yin D, Green

S, Bergsland EK. Figitumumab in patients with refractory metastatic colorectal cancer previously treated with standard therapies: a non-randomized, open-label, phase II trial. Cancer Chemother Pharmacol 2014;73(4):695–702.

412. Bellmunt J, Pons F, Foreshew A, Fay AP, Powles T, Porta C, Bracarda S, Lampron ME, Cerbone L, Sternberg CN, Hutson TE, Choueiri TK. Sequential targeted therapy after pazopanib therapy in patients with metastatic renal cell cancer: effi cacy and toxicity. Clin Genitourin Cancer 2014;12(4):262–269.

413. Buhrmann C, Kraehe P, Lueders C, Shayan P, Goel A, Shakibaei M. Cur-cumin suppresses crosstalk between colon cancer stem cells and stromal fi broblasts in the tumor microenvironment: potential role of EMT. PLoS One 2014;9(9):e107514.

414. Butcher LD, Garcia M, Arnold M, Ueno H, Goel A, Boland CR. Immune response to JC virus T antigen in patients with and without colorectal neoplasia. Gut Microbes 2014;5(4):468–475.

415. Cairncross JG, Wang M, Jenkins RB, Shaw EG, Giannini C, Brachman DG, Buckner JC, Fink KL, Souhami L, Laperriere NJ, Huse JT, Mehta MP, Curran WJ Jr. Benefi t from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH. J Clin Oncol 2014;32(8):783–790.

416. Chai X, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C, Garber JE, Neuhausen SL, Matloff E, Eeles R, Tung N, Weitzel JN, Couch FJ, Hulick PJ, Ganz PA, Daly MB, Olopade OI, Tomlinson G, Blum JL, Domchek SM, Chen J, Rebbeck TR. Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 2014;148(2):397–406.

417. Chen C, Borker R, Ewing J, Tseng WY, Hackshaw MD, Saravanan S, Dhanda R, Nadler E. Epidemiology, treatment patterns, and outcomes of metastatic soft tissue sarcoma in a community-based oncology network. Sarcoma 2014;2014:145764.

418. Cheng YS, Jordan L, Rees T, Chen HS, Oxford L, Brinkmann O, Wong D. Levels of potential oral cancer salivary mRNA biomarkers in oral cancer patients in remission and oral lichen planus patients. Clin Oral Investig 2014;18(3):985–993.

419. Christopher T, Gradishar WJ, O’Shaughnessy JA, Bramsen B, Lurie RH. Clinical roundtable monograph: eff ective management of qual-ity of life in metastatic breast cancer. Clin Adv Hematol Oncol 2014;12(2 Suppl 4):1–14.

420. Crapko M, Fleshman J. Minimally invasive surgery for rectal cancer. Ann Surg Oncol 2014;21(1):173–178.

421. Delaloge S, Wolp-Diniz R, Byrski T, Blum JL, Gonçalves A, Campone M, Lardelli P, Kahatt C, Nieto A, Cullell-Young M, Lubinski J. Activity of trabectedin in germline BRCA1/2-mutated metastatic breast can-cer: results of an international fi rst-in-class phase II study. Ann Oncol 2014;25(6):1152–1158.

422. EBCTCG (Early Breast Cancer Trialists’ Collaborative Group; O’Shaughnessy J), McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, Wang Y, Wang Z, Darby S. Eff ect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 2014;383(9935):2127–2135.

423. Escudier B, Michaelson MD, Motzer RJ, Hutson TE, Clark JI, Lim HY, Porfi ri E, Zalewski P, Kannourakis G, Staehler M, Tarazi J, Rosbrook B, Cisar L, Hariharan S, Kim S, Rini BI. Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial. Br J Cancer 2014;110(12):2821–2828.

424. Fizazi K, Scher HI, Molina A, Logothetis CJ, Chi KN, Jones RJ, Staff urth JN, North S, Vogelzang NJ, Saad F, Mainwaring P, Harland S, Goodman OB Jr, Sternberg CN, Li JH, Kheoh T, Haqq CM, de Bono JS; COU-AA-301 Investigators (Hutson T). Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: fi nal overall survival analy-sis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study. Lancet Oncol 2012;13(10):983–992.

425. Flaherty L, Hamid O, Linette G, Schuchter L, Hallmeyer S, Gonzalez R, Cowey CL, Pavlick A, Kudrik F, Curti B, Lawson D, Chapman PB,


279

Margolin K, Ribas A, McDermott D, Flaherty K, Cranmer L, Hodi FS, Day BM, Linke R, Hainsworth J. A single-arm, open-label, expanded access study of vemurafenib in patients with metastatic melanoma in the United States. Cancer J 2014;20(1):18–24.

426. Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA, Burt RW, Church JM, Dominitz JA, Johnson DA, Kaltenbach T, Levin TR, Lieberman DA, Robertson DJ, Syngal S, Rex DK. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastro-enterol 2014;109(8):1159–1179.

427. Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA, Burt RW, Church JM, Dominitz JA, Johnson DA, Kaltenbach T, Levin TR, Lieber-man DA, Robertson DJ, Syngal S, Rex DK; US Multi-Society Task Force on Colorectal Cancer. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2014;147(2):502–526.

428. Gradishar WJ, Twelves C, O’Shaughnessy JA. General discussion. Clin Adv Hematol Oncol 2014;12(2 Suppl 4):13.

429. Graham RL, Burch M, Krause JR. Adult T-cell leukemia/lymphoma. Proc (Bayl Univ Med Cent) 2014;27(3):235–238.

430. Grant MD. Cannula-assisted fl ap elevation (CAFE): a novel technique for developing fl aps during skin-sparing mastectomies. Ann Surg Oncol 2014 Sep 16 [Epub ahead of print].

431. Gronwald J, Robidoux A, Kim-Sing C, Tung N, Lynch HT, Foulkes WD, Manoukian S, Ainsworth P, Neuhausen SL, Demsky R, Eisen A, Singer CF, Saal H, Senter L, Eng C, Weitzel J, Moller P, Gilchrist DM, Olopade O, Ginsburg O, Sun P, Huzarski T, Lubinski J, Narod SA; Hereditary Breast Cancer Clinical Study Group (Blum J). Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 2014;146(2):421–427.

432. Guarinos C, Juárez M, Egoavil C, Rodríguez-Soler M, Pérez-Carbonell L, Salas R, Cubiella J, Rodríguez-Moranta F, de-Castro L, Bujanda L, Serradesanferm A, Nicolás-Pérez D, Herráiz M, Fernández-Bañares F, Herreros-de-Tejada A, Aguirre E, Balmaña J, Rincón ML, Pizarro A, Polo-Ortiz F, Castillejo A, Alenda C, Payá A, Soto JL, Jover R. Preva-lence and characteristics of MUTYH-associated polyposis in patients with multiple adenomatous and serrated polyps. Clin Cancer Res 2014;20(5):1158–1168.

433. Gupta V, Malone AK, Hari PN, Ahn KW, Hu ZH, Gale RP, Ballen KK, Hamadani M, Olavarria E, Gerds AT, Waller EK, Costa LJ, Antin JH, Kamble RT, van Besien KM, Savani BN, Schouten HC, Szer J, Cahn JY, de Lima MJ, Wirk B, Aljurf MD, Popat U, Bejanyan N, Litzow MR, Norkin M, Lewis ID, Hale GA, Woolfrey AE, Miller AM, Ustun C, Jagasia MH, Lill M, Maziarz RT, Cortes J, Kalaycio ME, Saber W. Reduced-intensity hematopoietic cell transplantation for patients with primary myelofi brosis: a cohort analysis from the center for international blood and marrow trans-plant research. Biol Blood Marrow Transplant 2014;20(1):89–97.

434. Hamid O, Ilaria R Jr, Garbe C, Wolter P, Maio M, Hutson TE, Arance A, Lorigan P, Lee J, Hauschild A, Mohr P, Hahka-Kemppinen M, Kaiser C, Turner PK, Conti I, Grob JJ. A randomized, open-label clinical trial of tasisulam sodium versus paclitaxel as second-line treatment in patients with metastatic melanoma. Cancer 2014;120(13):2016–2024.

435. Harmon CS, Deprimo SE, Figlin RA, Hudes GR, Hutson TE, Michaelson MD, Négrier S, Kim ST, Huang X, Williams JA, Eisen T, Motzer RJ. Circulating proteins as potential biomarkers of sunitinib and interferon-α effi cacy in treatment-naïve patients with metastatic renal cell carcinoma. Cancer Chemother Pharmacol 2014;73(1):151–161.

436. Hatanpaa KJ, Hu T, Vemireddy V, Foong C, Raisanen JM, Oliver D, Hiemenz MC, Burns DK, White CL 3rd, Whitworth LA, Mickey B, Stegner M, Habib AA, Fink K, Maher EA, Bachoo RM. High expres-sion of the stem cell marker nestin is an adverse prognostic factor in WHO grade II-III astrocytomas and oligoastrocytomas. J Neurooncol 2014;117(1):183–189.

437. Hayes SM, Bowser AD, Mortimer J, Lazure P, Peterson E, Hutson TE, Rini B. Practice challenges aff ecting optimal care as identifed by US medical oncologists who treat renal cell carcinomas. J Community Support Oncol 2014;12(6):197–204.

438. Heym KM, Gressett Ussery SM, Trinkman H, Philpot LM. Nonhema-tologic toxicity of imatinib mesylate in pediatric patients with chronic myelogenous leukemia: a predominance of musculoskeletal pain. J Pediatr Hematol Oncol 2014 Nov 4 [Epub ahead of print].

439. Hur K, Cejas P, Feliu J, Moreno-Rubio J, Burgos E, Boland CR, Goel A. Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis. Gut 2014;63(4):635–646.

440. Hutson TE, Bukowski RM, Rini BI, Gore ME, Larkin JM, Figlin RA, Barrios CH, Escudier B, Lin X, Fly K, Martell B, Matczak E, Motzer RJ. Effi cacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma. Br J Cancer 2014;110(5):1125–1132.

441. Hutson TE, Escudier B, Esteban E, Bjarnason GA, Lim HY, Pittman KB, Senico P, Niethammer A, Lu DR, Hariharan S, Motzer RJ. Randomized phase III trial of temsirolimus versus sorafenib as second-line therapy after sunitinib in patients with metastatic renal cell carcinoma. J Clin Oncol 2014;32(8):760–767.

442. Johnson DA, Barkun AN, Cohen LB, Dominitz JA, Kaltenbach T, Martel M, Robertson DJ, Boland CR, Giardello FM, Lieberman DA, Levin TR, Rex DK; US Multi-Society Task Force on Colorectal Cancer. Optimiz-ing adequacy of bowel cleansing for colonoscopy: recommendations from the US multi-society task force on colorectal cancer. Gastroen-terology 2014;147(4):903–924. Also published in Am J Gastroenterol 2014;109(10):1528–1545 and Gastrointest Endosc 2014;80(4):543–562.

443. Jones C, LeDay TV, Miller AM. Acute myelogenous leukemia at Baylor Charles A. Sammons Cancer Center, 2010 to 2012: retrospective analysis of molecular genetic evaluation. Proc (Bayl Univ Med Cent) 2014;27(4):299–304.

444. Jones C, Levy Y, Tong AW. Elevated serum erythropoietin in a patient with polycythaemia vera presenting with Budd-Chiari syndrome. BMJ Case Rep 2014;2014.

445. Jotte RM, Von Hoff DD, Braiteh F, Becerra CR, Richards DA, Smith DA, Garbo L, Stephenson J, Conkling PR, Robert-Vizcarrondo F, Chen J, Turner PK, Chow KH, Tai DF, Ilaria R Jr. An innovative, multi-arm, complete phase 1b study of the novel anti-cancer agent tasisulam in patients with advanced solid tumors. Invest New Drugs 2014 Sep 28 [Epub ahead of print].

446. Klos CL, Montenegro G, Jamal N, Wise PE, Fleshman JW, Safar B, Dharmarajan S. Segmental versus extended resection for sporadic colorec-tal cancer in young patients. J Surg Oncol 2014;110(3):328–332.

447. Kotsopoulos J, Lubinski J, Moller P, Lynch HT, Singer CF, Eng C, Neuhausen SL, Karlan B, Kim-Sing C, Huzarski T, Gronwald J, McCuaig J, Senter L, Tung N, Ghadirian P, Eisen A, Gilchrist D, Blum JL, Zakalik D, Pal T, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group. Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers. Breast Cancer Res Treat 2014;143(3):579–586.

448. Landry CS, Cavaness K, Celinski S, Preskitt J. Biochemical prognostic indicators for pancreatic neuroendocrine tumors and small bowel neu-roendocrine tumors. Gland Surg 2014;3(4):215–218.

449. Larkin J, Fishman M, Wood L, Negrier S, Olivier K, Pyle L, Gorbunova V, Jonasch E, Andrews L, Staehler M. Axitinib for the treatment of meta-static renal cell carcinoma: recommendations for therapy management to optimize outcomes. Am J Clin Oncol 2014;37(4):397–403.

450. Lechowicz MJ, Lazarus HM, Carreras J, Laport GG, Cutler CS, Wiernik PH, Hale GA, Maharaj D, Gale RP, Rowlings PA, Freytes CO, Miller AM, Vose JM, Maziarz RT, Montoto S, Maloney DG, Hari PN. Al-logeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome. Bone Marrow Transplant 2014;49(11):1360–1365.

451. Levy RA, Mardones MA, Burch MM, Krause JR. Myeloid sarcoma as the presenting symptom of chronic myelogenous leukemia blast crisis. Proc (Bayl Univ Med Cent) 2014;27(3):246–249.

452. Link A, Balaguer F, Nagasaka T, Boland CR, Goel A. MicroRNA miR-J1-5p as a potential biomarker for JC virus infection in the gastrointestinal tract. PLoS One 2014;9(6):e100036.

453. McClune BL, Ahn KW, Wang HL, Antin JH, Artz AS, Cahn JY, Deol A, Freytes CO, Hamadani M, Holmberg LA, Jagasia MH, Jakubowski AA, Kharfan-Dabaja MA, Lazarus HM, Miller AM, Olsson R, Pedersen


280280

TL, Pidala J, Pulsipher MA, Rowe JM, Saber W, van Besien KW, Waller EK, Aljurf MD, Akpek G, Bacher U, Chao NJ, Chen YB, Cooper BW, Dehn J, de Lima MJ, Hsu JW, Lewis ID, Marks DI, McGuirk J, Cairo MS, Schouten HC, Szer J, Ramanathan M, Savani BN, Seftel M, Socie G, Vij R, Warlick ED, Weisdorf DJ. Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival. Biol Blood Marrow Transplant 2014;20(7):960–968.

454. McIntyre K, O’Shaughnessy J, Schwartzberg L, Glück S, Berrak E, Song JX, Cox D, Vahdat LT. Phase 2 study of eribulin mesylate as fi rst-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer. Breast Cancer Res Treat 2014;146(2):321–328.

455. Molina AM, Hutson TE, Larkin J, Gold AM, Wood K, Carter D, Motzer R, Michaelson MD. A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC). Cancer Chemother Pharmacol 2014;73(1):181–189.

456. Monson JR, Probst CP, Wexner SD, Remzi FH, Fleshman JW, Garcia-Aguilar J, Chang GJ, Dietz DW; Consortium for Optimiz-ing the Treatment of Rectal Cancer (OSTRiCh). Failure of evidence-based cancer care in the United States: the association between rectal cancer treatment, cancer center volume, and geography. Ann Surg 2014;260(4):625–631.

457. Moreau P, Mateos MV, Bladé J, Benboubker L, de la Rubia J, Facon T, Comenzo R, Fay J, Masterson T, Qin X, Ahmadi T, Schecter J, San-Miguel J. An open-label, multicenter, phase 1b study of daratumumab in combination with backbone regimens in patients with multiple myeloma. Blood 2014;124(2):Abstract 176.

458. Motzer RJ, Hutson TE, Hudes GR, Figlin RA, Martini JF, English PA, Huang X, Valota O, Williams JA. Investigation of novel circulating proteins, germ line single-nucleotide polymorphisms, and molecular tumor markers as potential effi cacy biomarkers of fi rst-line sunitinib therapy for advanced renal cell carcinoma. Cancer Chemother Pharmacol 2014;74(4):739–750.

459. Motzer RJ, Hutson TE, McCann L, Deen K, Choueiri TK. Overall survival in renal-cell carcinoma with pazopanib versus sunitinib. N Engl J Med 2014;370(18):1769–1770.

460. Muss H, Cortes J, Vahdat LT, Cardoso F, Twelves C, Wanders J, Dutcus CE, Yang J, Seegobin S, O’Shaughnessy J. Eribulin monotherapy in patients aged 70 years and older with metastatic breast cancer. Oncologist 2014;19(4):318–327.

461. Myerson RJ, Tan B, Hunt S, Olsen J, Birnbaum E, Fleshman J, Gao F, Hall L, Kodner I, Lockhart AC, Mutch M, Naughton M, Picus J, Rigden C, Safar B, Sorscher S, Suresh R, Wang-Gillam A, Parikh P. Five fractions of radiation therapy followed by 4 cycles of FOLFOX chemotherapy as preoperative treatment for rectal cancer. Int J Radiat Oncol Biol Phys 2014;88(4):829–836.

462. Okugawa Y, Toiyama Y, Goel A. An update on microRNAs as colorectal cancer biomarkers: where are we and what’s next? Expert Rev Mol Diagn 2014;14(8):999–1021.

463. Okugawa Y, Toiyama Y, Hur K, Toden S, Saigusa S, Tanaka K, Inoue Y, Mohri Y, Kusunoki M, Boland CR, Goel A. Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis. Carcinogenesis 2014;35(12):2731–2739.

464. O’Shaughnessy J, Schwartzberg L, Danso MA, Miller KD, Rugo HS, Neubauer M, Robert N, Hellerstedt B, Saleh M, Richards P, Specht JM, Yardley DA, Carlson RW, Finn RS, Charpentier E, Garcia-Ribas I, Winer EP. Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer. J Clin Oncol 2014;32(34):3840–3847.

465. O’Shaughnessy JA. Highlights in metastatic breast cancer from the 2013 San Antonio Breast Cancer Symposium (SABCS). Clin Adv Hematol Oncol 2014;12(3 Suppl 7):3–17.

466. O’Shaughnessy JA. Improving quality of life in patients with metastatic breast cancer. Clin Adv Hematol Oncol 2014;12(2 Suppl 4):10–12.

467. Pan IW, Mallick R, Dhanda R, Nadler E. Treatment patterns and out-comes in patients with non-squamous advanced non-small cell lung

cancer receiving second-line treatment in a community-based oncology network. Lung Cancer 2013;82(3):469–476.

468. Parikh F, Duluc D, Imai N, Clark A, Misiukiewicz K, Bonomi M, Gupta V, Patsias A, Parides M, Demicco EG, Zhang DY, Kim-Schulze S, Kao J, Gnjatic S, Oh S, Posner MR, Sikora AG. Chemoradiotherapy-induced upregulation of PD-1 antagonizes immunity to HPV-related oropharyn-geal cancer. Cancer Res 2014;74(24):7205–7216.

469. Pemmaraju N, Gill J, Gupta S, Krause JR. Triple-hit lymphoma. Proc (Bayl Univ Med Cent) 2014;27(2):125–127.

470. Perez-Carbonell L, Balaguer F, Toiyama Y, Egoavil C, Rojas E, Guarinos C, Andreu M, Llor X, Castells A, Jover R, Boland CR, Goel A. IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer. PLoS One 2014;9(8):e104285.

471. Podduturi V, Armstrong-Briley DR, Guileyardo JM. Sudden death by pulmonary thromboembolism due to a large uterine leiomyo-ma with a parasitic vein to the mesentery. Case Rep Obstet Gynecol 2014;2014:181265.

472. Podduturi V, Campa-Thompson MM, Zhou XJ, Guileyardo JM. Malignant rhabdoid tumor of the kidney arising in an adult patient. Proc (Bayl Univ Med Cent) 2014;27(3):239–241.

473. Podduturi V, Guileyardo JM. Clear cell carcinoma of the ovary associated with increased risk of venous thrombosis. Proc (Bayl Univ Med Cent) 2014;27(4):338–340.

474. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected bur-den of thyroid, liver, and pancreas cancers in the United States. Cancer Res 2014;74(11):2913–2921.

475. Rhees J, Arnold M, Boland CR. Inversion of exons 1-7 of the MSH2 gene is a frequent cause of unexplained Lynch syndrome in one local population. Fam Cancer 2014;13(2):219–225.

476. Ribas A, Zhang W, Chang I, Shirai K, Ernstoff MS, Daud A, Cowey CL, Daniels G, Seja E, O’Laco E, Glaspy JA, Chmielowski B, Hill T, Joe AK, Grippo JF. Th e eff ects of a high-fat meal on single-dose vemurafenib pharmacokinetics. J Clin Pharmacol 2014;54(4):368–374.

477. Robinson S, Levy Y, Maisel C, Tong AW. Haematological complete remis-sion by ponatinib and bortezomib in a patient with relapsed, Ph+ pre-B acute lymphoblastic leukaemia. BMJ Case Rep 2014;2014.

478. Robinson SD, O’Shaughnessy JA, Cowey CL, Konduri K. BRAF V600E-mutated lung adenocarcinoma with metastases to the brain responding to treatment with vemurafenib. Lung Cancer 2014;85(2):326–330.

479. Schnadig ID, Hutson TE, Chung H, Dhanda R, Halm M, Forsyth M, Vogelzang NJ. Dosing patterns, toxicity, and outcomes in patients treated with fi rst-line sunitinib for advanced renal cell carcinoma in community-based practices. Clin Genitourin Cancer 2014;12(6):413–421.

480. Schulz E, Klampfl P, Holzapfel S, Janecke AR, Ulz P, Renner W, Kashofer K, Nojima S, Leitner A, Zebisch A, Wölfl er A, Hofer S, Gerger A, Lax S, Beham-Schmid C, Steinke V, Heitzer E, Geigl JB, Windpassinger C, Hoefl er G, Speicher MR, Boland CR, Kumanogoh A, Sill H. Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X. Nat Commun 2014;5:5191.

481. Shakibaei M, Buhrmann C, Kraehe P, Shayan P, Lueders C, Goel A. Cur-cumin chemosensitizes 5-fl uorouracil resistant MMR-defi cient human colon cancer cells in high density cultures. PLoS One 2014;9(1):e85397.

482. Shanafelt TD, Gradishar WJ, Kosty M, Satele D, Chew H, Horn L, Clark B, Hanley AE, Chu Q, Pippen J, Sloan J, Raymond M. Burnout and career satisfaction among US oncologists. J Clin Oncol 2014;32(7):678–686.

483. Shanafelt TD, Raymond M, Kosty M, Satele D, Horn L, Pippen J, Chu Q, Chew H, Clark WB, Hanley AE, Sloan J, Gradishar WJ. Satisfac-tion with work-life balance and the career and retirement plans of US oncologists. J Clin Oncol 2014;32(11):1127–1135.

484. Shia J, Stadler ZK, Weiser MR, Vakiani E, Mendelsohn R, Markowitz AJ, Shike M, Boland CR, Klimstra DS. Mismatch repair defi cient-crypts in non-neoplastic colonic mucosa in Lynch syndrome: insights from an illustrative case. Fam Cancer 2014 Aug 31 [Epub ahead of print].

485. Shigeyasu K, Tazawa H, Hashimoto Y, Mori Y, Nishizaki M, Kishimoto H, Nagasaka T, Kuroda S, Urata Y, Goel A, Kagawa S, Fujiwara T. Fluo-rescence virus-guided capturing system of human colorectal circulating


281

tumour cells for non-invasive companion diagnostics. Gut 2014 May 28 [Epub ahead of print].

486. Stone MJ, Trotter J, Fulmer M, Klintmalm G. Transplantation for Budd-Chiari syndrome. In Busuttil RW, Klintmalm GB, eds. Transplantation of the Liver, 3rd ed. Saunders, 2014.

487. Suttle AB, Ball HA, Molimard M, Hutson TE, Carpenter C, Rajagopalan D, Lin Y, Swann S, Amado R, Pandite L. Relationships between pazo-panib exposure and clinical safety and effi cacy in patients with advanced renal cell carcinoma. Br J Cancer 2014;111(10):1909–1916.

488. Th omas CA, Guileyardo JM, Krause JR. An intravascular lymphoma with extravascular tendencies. Proc (Bayl Univ Med Cent) 2014;27(4):341–343.

489. Toiyama Y, Hur K, Tanaka K, Inoue Y, Kusunoki M, Boland CR, Goel A. Serum miR-200c is a novel prognostic and metastasis-predictive biomark-er in patients with colorectal cancer. Ann Surg 2014;259(4):735–743.

490. Toiyama Y, Okugawa Y, Goel A. DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer. Biochem Biophys Res Commun 2014;455(1–2):43–57.

491. Toiyama Y, Tanaka K, Kitajima T, Shimura T, Kawamura M, Kawamoto A, Okugawa Y, Saigusa S, Hiro J, Inoue Y, Mohri Y, Goel A, Kusunoki M. Elevated serum angiopoietin-like protein 2 correlates with the metastatic properties of colorectal cancer: a serum biomarker for early diagnosis and recurrence. Clin Cancer Res 2014;20(23):6175–6186.

492. Tripathy D, Rugo HS, Kaufman PA, Swain S, O’Shaughnessy J, Jahanzeb M, Mason G, Beattie M, Yoo B, Lai C, Masaquel A, Hurvitz S. Th e Syst-HERs registry: an observational cohort study of treatment patterns and out-comes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. BMC Cancer 2014; 14(1):307.

493. Vogelzang NJ, Hackshaw MD, Hutson TE, Bhowmik D, Yap M, Rembert D, Jonasch E. First-line and sequential use of pazopanib followed by mammalian target of rapamycin inhibitor therapy among patients with advanced renal cell carcinoma in a US community oncol-ogy setting. Clin Genitourin Cancer 2014 Nov 15 [Epub ahead of print].

494. Warlick ED, Paulson K, Brazauskas R, Zhong X, Miller AM, Camitta BM, George B, Savani BN, Ustun C, Marks DI, Waller EK, Baron F, Freytes CO, Socie G, Akpek G, Schouten HC, Lazarus HM, Horwitz EM, Koreth J, Cahn JY, Bornhauser M, Seftel M, Cairo MS, Laughlin MJ, Sabloff M, Ringdén O, Gale RP, Kamble RT, Vij R, Gergis U, Mathews V, Saber W, Chen YB, Liesveld JL, Cutler CS, Ghobadi A, Uy GL, Eapen M, Weisdorf DJ, Litzow MR. Eff ect of postremission therapy before reduced-intensity conditioning allogeneic transplanta-tion for acute myeloid leukemia in fi rst complete remission. Biol Blood Marrow Transplant 2014;20(2):202–208.

495. Wilks S, Puhalla S, O’Shaughnessy J, Schwartzberg L, Berrak E, Song J, Cox D, Vahdat L. Phase 2, multicenter, single-arm study of eribulin mesyl-ate with trastuzumab as fi rst-line therapy for locally recurrent or metastatic HER2-positive breast cancer. Clin Breast Cancer 2014;14(6):405–412.

496. Wilson TR, Xiao Y, Spoerke JM, Fridlyand J, Koeppen H, Fuentes E, Huw LY, Abbas I, Gower A, Schleifman EB, Desai R, Fu L, Sumiyo-shi T, O’Shaughnessy JA, Hampton GM, Lackner MR. Development of a robust RNA-based classifi er to accurately determine ER, PR, and HER2 status in breast cancer clinical samples. Breast Cancer Res Treat 2014;148(2):315–325.

497. Yamada A, Cox MA, Gaff ney KA, Moreland A, Boland CR, Goel A. Technical factors involved in the measurement of circulating microRNA biomarkers for the detection of colorectal neoplasia. PLoS One 2014;9(11):e112481.

498. Yamada A, Minamiguchi S, Sakai Y, Horimatsu T, Muto M, Chiba T, Boland CR, Goel A. Colorectal advanced neoplasms occur through dual carcinogenesis pathways in individuals with coexisting serrated polyps. PLoS One 2014;9(5):e98059.

499. Zhrebker L, Cooper B, Krause JR. Systemic mastocytosis with associated acute myelogenous leukemia. Proc (Bayl Univ Med Cent) 2014;27(1):22–24.

OPHTHALMOLOGY500. Vrcek I, Hogan RN, Gilliland G. Orbital liposarcoma masquerading as

a hemangioma. Proc (Bayl Univ Med Cent) 2014;27(4):359–360.

501. Yang P, Michaels KV, Courtney RJ, Wen Y, Greninger DA, Reznick L, Karr DJ, Wilson LB, Weleber RG, Pennesi ME. Retinal morphology of patients with achromatopsia during early childhood: implications for gene therapy. JAMA Ophthalmol 2014;132(7):823–831.

ORAL AND MAXILLOFACIAL SURGERY502. Cevidanes LH, Walker D, Schilling J, Sugai J, Giannobile W, Paniagua

B, Benavides E, Zhu H, Marron JS, Jung BT, Baranowski D, Rhodes J, Nackley A, Lim PF, Ludlow JB, Nguyen T, Goncalves JR, Wolford L, Kapila S, Styner M. 3D osteoarthritic changes in TMJ condylar mor-phology correlates with specifi c systemic and local biomarkers of disease. Osteoarthritis Cartilage 2014;22(10):1657–1667.

503. Naidu A, Malmquist MP, Denham CA, Schow SR. Management of central giant cell granuloma with subcutaneous denosumab therapy. J Oral Maxillofac Surg 2014;72(12):2469–2484.

504. Rodrigues DB, Wolford LM, Figueiredo LM, Adams GQ. Management of ankylosed maxillary canine with single-tooth osteotomy in conjunction with orthognathic surgery. J Oral Maxillofac Surg 2014;72(12):2419.e1–6.

505. Wolford L. Orthognathic surgery. Formedika Dental and Medical Educa-tion 2014; 1–7.

506. Wolford LM. Can orthodontic relapse be blamed on the temporoman-dibular joint? J Orthod Sci 2014;3(4):95–105.

507. Wolford LM, Mercuri LG, Schneiderman ED, Movahed R, Allen W. Twenty-year follow-up study on a patient-fi tted temporomandibular joint prosthesis: the Techmedica/TMJ Concepts device. J Oral Maxillofac Surg 2014 Nov 14 [Epub ahead of print].

508. Wolford LM, Movahed R, Dhameja A, Allen WR. Low condylec-tomy and orthognathic surgery to treat mandibular condylar osteo-chondroma: a retrospective review of 37 cases. J Oral Maxillofac Surg 2014;72(9):1704–1728.

509. Wolford LM, Movahed R, Perez DE. A classifi cation system for condi-tions causing condylar hyperplasia. J Oral Maxillofac Surg 2014;72(3):567–595.

510. Wolford LM, Movahed R. Concomitant TMJ and orthognathic sur-gery: diagnosis and treatment planning. Oral and Maxillofacial Surgery Knowledge Update.

ORTHOPEDIC SURGERY511. Bariteau JT, Murillo DM, Tenenbaum SA, Brodsky JW. Joint salvage

after neglected intra-articular physeal fracture of the hallux in high-level gymnasts. Foot Ankle Spec 2014 Jul 17 [Epub ahead of print].

512. Bariteau JT, Tenenbaum S, Rabinovich A, Brodsky JW. Charcot arthropa-thy of the foot and ankle in patients with idiopathic neuropathy. Foot Ankle Int 2014;35(10):996–1001.

513. Brodsky JW, Verschae G, Tenenbaum S. Surgical correction of severe deformity of the ankle and hindfoot by arthrodesis using a compress-ing retrograde intramedullary nail. Foot Ankle Int 2014;35(4):360–367.

514. Goz V, McCarthy I, Weinreb JH, Dallas K, Bendo JA, Lafage V, Errico TJ. Venous thromboembolic events after spinal fusion: which patients are at high risk? J Bone Joint Surg Am 2014;96(11):936–942.

515. Hung M, Baumhauer JF, Brodsky JW, Cheng C, Ellis SJ, Franklin JD, Hon SD, Ishikawa SN, Latt LD, Phisitkul P, Saltzman CL, SooHoo NF, Hunt KJ; Orthopaedic Foot & Ankle Outcomes Research (OFAR) of the American Orthopaedic Foot & Ankle Society (AOFAS). Psycho-metric comparison of the PROMIS physical function CAT with the FAAM and FFI for measuring patient-reported outcomes. Foot Ankle Int 2014;35(6):592–599.

516. Hunt KJ, Alexander I, Baumhauer J, Brodsky J, Chiodo C, Daniels T, Davis WH, Deland J, Ellis S, Hung M, Ishikawa SN, Latt LD, Phisitkul P, SooHoo NF, Yang A, Saltzman CL; OFAR (Orthopaedic Foot and Ankle Outcomes Research Network). Th e Orthopaedic Foot and Ankle Outcomes Research (OFAR) network: feasibility of a multicenter net-work for patient outcomes assessment in foot and ankle. Foot Ankle Int 2014;35(9):847–854.

517. Martin HD, Hatem MA, Kivlan BR, Martin RL. Function of the liga-mentum teres in limiting hip rotation: a cadaveric study. Arthroscopy 2014;30(9):1085–1091.


282282

518. Martin HD, Kivlan BR, Palmer IJ, Martin RL. Diagnostic accuracy of clinical tests for sciatic nerve entrapment in the gluteal region. Knee Surg Sports Traumatol Arthrosc 2014;22(4):882–888.

519. Martin HD, Palmer IJ, Hatem M. Monopolar radiofrequency use in deep gluteal space endoscopy: sciatic nerve safety and fl uid temperature. Arthroscopy 2014;30(1):60–64.

520. Martínez D, Gómez-Hoyos J, Márquez W, Gallo J. Factors associated with the failure of arthroscopic surgery treatment in patients with femo-roacetabular impingement: A cohort study. Rev Esp Cir Ortop Traumatol 2014 Oct 23 [Epub ahead of print].

521. Matsuda DK, Gupta N, Martin HD. Closed intramedullary derotational osteotomy and hip arthroscopy for cam femoroacetabular impingement from femoral retroversion. Arthrosc Tech 2014;3(1):e83–e88.

522. Mayich DJ, Novak A, Vena D, Daniels TR, Brodsky JW. Gait analysis in orthopedic foot and ankle surgery—topical review, part 1: principles and uses of gait analysis. Foot Ankle Int 2014;35(1):80–90.

523. Moen TC, Rudolph GH, Caswell K, Espinoza C, Burkhead WZ Jr, Krishnan SG. Complications of shoulder arthroscopy. J Am Acad Orthop Surg 2014;22(7):410–419.

524. Novak AC, Mayich DJ, Perry SD, Daniels TR, Brodsky JW. Gait anal-ysis for foot and ankle surgeons—topical review, part 2: approaches to multisegment modeling of the foot. Foot Ankle Int 2014;35(2):178–191.

525. Stockton KG, Brodsky JW. Peroneus longus tears associated with pathol-ogy of the os peroneum. Foot Ankle Int 2014;35(4):346–352.

526. Tenenbaum S, Coleman SC, Brodsky JW. Improvement in gait fol-lowing combined ankle and subtalar arthrodesis. J Bone Joint Surg Am 2014;96(22):1863–1869.

527. Tenenbaum S, Stockton KG, Bariteau JT, Brodsky JW. Salvage of avas-cular necrosis of the talus by combined ankle and hindfoot arthrodesis without structural bone graft. Foot Ankle Int 2014 Nov 6 [Epub ahead of print].

OTOLARYNGOLOGY528. Gordin EA, Ducic Y. Microvascular free tissue reconstruction in

the patient with multiple courses of radiation. Laryngoscope 2014;124(10):2252–2256.

529. Kadakia S, Helman SN, Badhey AK, Saman M, Ducic Y. Treacher Collins Syndrome: the genetics of a craniofacial disease. Int J Pediatr Otorhino-laryngol 2014;78(6):893–898.

530. Lee TS, Ducic Y, Gordin E, Stroman D. Management of carotid artery trauma. Craniomaxillofac Trauma Reconstr 2014;7(3):175–189.

531. Saman M, Kadakia S, Ducic Y. Postoperative maxillomandibular fi xation after open reduction of mandible fractures. JAMA Facial Plast Surg 2014;16(6):410–413.

PATHOLOGYNote: See also Oncology and other departments in which pathologists were fi rst authors or coauthors.532. Krause JR, Robinson SD, Vance EA. Multicentric Castleman’s disease in

an individual with HIV. Proc (Bayl Univ Med Cent) 2014;27(1):28–30.533. Levy RA, Winham WM, Bryant CS, Quick CM. Smooth muscle

neoplasms of the vulva masquerading as Bartholin gland duct cysts. Proc (Bayl Univ Med Cent) 2014;27(1):25–27.

534. Soto LR, Levine HR, Celinski SA, Guileyardo JM. Fatal abdomi-nal hemorrhage associated with gallbladder perforation due to large gallstones. Proc (Bayl Univ Med Cent) 2014;27(2):131–132.

PEDIATRICS/NEONATOLOGY535. Bailey A, Istre GR, Nie C, Evans J, Quinton R, Stephens-Stidham S.

Truancy and injury-related mortality. Injury Prevention 2014 Sep 10 [Epub ahead of print].

536. Blakeney S, Seale J, Hendrikson H, Whitfi eld J. Growth faltering in VLBW infants fed breast milk fortifi ed with new sterile liquid fortifi er. J Pediatr Gastroenterol Nutr 2014;59(5):e46–e47.

537. Istre GR, McCoy MA, Moore BJ, Roper C, Stephens-Stidham S, Barnard JJ, Carlin DK, Stowe M, Anderson RJ. Preventing deaths and injuries

from house fi res: an outcome evaluation of a community-based smoke alarm installation programme. Injury Prevention 2014;20(2):97–102.

538. Jacob J, Kamitsuka M, Clark RH, Kelleher AS, Spitzer AR. Etiologies of NICU deaths. Pediatrics 2014 Dec 8 [Epub ahead of print].

539. McCoy MA, Roper C, Campa E, Stephens-Stidham S, Carlin DK, Istre GR. How long do smoke alarms function? A cross-sectional follow-up survey of a smoke alarm installation programme. Injury Prevention 2014;20(2):103–107.

540. Tolia VN, Murthy K, McKinley PS, Bennett MM, Clark RH. Th e eff ect of the national shortage of vitamin A on death or chronic lung disease in ex-tremely low-birth-weight infants. JAMA Pediatr 2014;168(11):1039–1044.

PHYSICAL MEDICINE AND REHABILITATIONNote: See also Trauma.541. Dixon-Ibarra A, Vanderbom K, Dugala A, Driver S. Systematic frame-

work to evaluate the status of physical activity research for persons with multiple sclerosis. Disabil Health J 2014;7(2):151–156.

542. Fazio C. Functional electrical stimulation for incomplete spinal cord injury. Proc (Bayl Univ Med Cent) 2014;27(4):353–355.

543. Harris CL, Shahid S. Physical therapy–driven quality improvement to promote early mobility in the intensive care unit. Proc (Bayl Univ Med Cent) 2014;27(3):203–207.

544. Swank C, Burns R, Weakley J, Suter R. Clinical characteristics and functional outcomes after West Nile neuroinvasive disease: a case series. Osteopathic Fam Phys 2014;6(4):32–36.

545. Vanderbom KA, Driver S, Nery-Hurwit M. A systematic framework to classify physical activity research for individuals with spina bifi da. Disabil Health J 2014;7(1):36–41.

PULMONOLOGY/INTENSIVE CARE/SLEEP MEDICINE546. Al Ashry HS, Modrykamien AM. Humidifi cation during mechanical

ventilation in the adult patient. Biomed Res Int 2014;2014:715434. 547. Jackson BE, Coultas DB, Ashmore J, Russo R, Peoples J, Uhm M, Singh

KP, Bae S. Domain-specifi c self-effi cacy is associated with measures of functional capacity and quality of life among patients with moderate to severe chronic obstructive pulmonary disease. Ann Am Th orac Soc 2014;11(3):310–315.

548. Millard M, Hart M, Barnes S. Validation of Rules of TwoΤΜ as a paradigm for assessing asthma control. Proc (Bayl Univ Med Cent) 2014;27(2):79–82.

549. Ritz T, Rosenfi eld D, Steele AM, Millard MW, Meuret AE. Control-ling asthma by training of Capnometry-Assisted Hypoventilation (CATCH) vs slow breathing: a randomized controlled trial. Chest 2014;146(5):1237–1247.

RADIOLOGYNote: See also Oncology, Neurology, and other departments in which radiologists were fi rst authors or coauthors.550. Benson BW, Flint DJ, Liang H, Opatowsky MJ. Advances in diagnos-

tic imaging for pathologic conditions of the jaws. Head Neck Pathol 2014;8(4):383–391.

551. Griff eth LK, Hillner BE, Shields AF, Siegel BA. Positron emission tomography for subsequent treatment strategy in oncology. J Clin Oncol 2014;32(25):2811–2812.

552. Levine H, Zarghouni M, Cannon W. Imaging manifestations of a dreaded obstetrician complication in the immediate postpartum period. Proc (Bayl Univ Med Cent) 2014;27(2):141–142.

553. Louis TH, Felter DF. Mucocele of the appendix. Proc (Bayl Univ Med Cent) 2014;27(1):33–34.

554. Nickell LT Jr, Lichtenberger JP 3rd, Khorashadi L, Abbott GF, Carter BW. Multimodality imaging for characterization, classifi cation, and staging of malignant pleural mesothelioma. Radiographics 2014;34(6):1692–1706.

555. Saad AF, Nickell LT, Heithaus RE, Shamim SA, Opatowsky MJ, Layton KF. Basilar artery thrombosis in the setting of antiphospholipid syndrome. Proc (Bayl Univ Med Cent) 2014;27(3):210–212.

556. Weir VJ, Zhang J, Bruner AP. Impact of physician practice on patient radiation dose during CT guided biopsy procedures. J Xray Sci Technol 2014;22(3):309–319.


283

RHEUMATOLOGY557. Cush JJ, Kavanaugh A. Pregnancy and rheumatoid arthritis—do not

let the perfect become the enemy of the good. Curr Opin Rheumatol 2014;26(3):299–301.

558. Kavanaugh A, Cush JJ, Ahmed MS, Bermas BL, Chakravarty E, Chambers C, Clowse M, Curtis JR, Dao K, Hankins GD, Koren G, Kim SC, Lapteva L, Mahadevan U, Moore T, Nolan M, Ren Z, Sammaritano LR, Seymour S, Weisman MH. Proceedings from the ACR Reproductive Health Summit: Th e management of fertility, pregnancy and lactation in women with autoimmune and systemic infl ammatory diseases. Arthritis Care Res (Hoboken) 2014 Nov 10 [Epub ahead of print].

SURGERYNote: Most surgery articles are subclassifi ed by specialty, even if general surgeons were fi rst authors or coauthors.559. Laux AT, Testa G, Goldstein RM, Cavaness KM. Th e management of

a complex bile duct injury after laparoscopic cholecystectomy. Am Surg 2014;80(6):E175–E178.

560. Williams SB, Matin SF, Matin S, Subbarao CD. Implementation of a very low calorie diet in patients undergoing urologic surgery: room for improvement? Clin Genitourin Cancer 2014 Dec 30 [Epub ahead of print].

561. Xiao Y, Jones A, Zhang BB, Bennett M, Mears SC, Mabrey JD, Kennerly D. Team consistency and occurrences of prolonged operative time, pro-longed hospital stay, and hospital readmission: a retrospective analysis. World J Surg 2014 Dec 4 [Epub ahead of print].

TRANSPLANTATION (ORGAN AND PANCREATIC CELLS)562. Asrani SK, Wiesner RH, Trotter JF, Klintmalm G, Katz E, Maller E,

Roberts J, Kneteman N, Teperman L, Fung JJ, Millis JM. De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective random-ized trial. Am J Transplant 2014;14(2):356–366.

563. Balamurugan AN, Naziruddin B, Lockridge A, Tiwari M, Loganathan G, Takita M, Matsumoto S, Papas K, Trieger M, Rainis H, Kin T, Kay TW, Wease S, Messinger S, Ricordi C, Alejandro R, Markmann J, Kerr-Conti J, Rickels MR, Liu C, Zhang X, Witkowski P, Posselt A, Maffi P, Secchi A, Berney T, O’Connell PJ, Hering BJ, Barton FB. Islet product char-acteristics and factors related to successful human islet transplantation from the Collaborative Islet Transplant Registry (CITR) 1999-2010. Am J Transplant 2014;14(11):2595–2606.

564. Bellin MD, Gelrud A, Arreaza-Rubin G, Dunn TB, Humar A, Morgan KA, Naziruddin B, Rastellini C, Rickels MR, Schwarzenberg SJ, Andersen DK. Total pancreatectomy with islet autotransplantation: summary of a National Institute of Diabetes and Digestive and Kidney diseases workshop. Pancreas 2014;43(8):1163–1171.

565. Benjamin MM, Dasher KJ, Trotter JF. A comparison of outcomes between OKT3 and antithymocyte globulin for treatment of steroid-resistant rejection in hepatitis C liver transplant recipients. Transplanta-tion 2014;97(4):470–473.

566. Busuttil RW, Klintmalm GB, eds. Transplantation of the Liver, 3rd ed. Saunders, 2014.

567. Campos-Varela I, Lai JC, Verna EC, O’Leary JG, Todd Stravitz R, Forman LM, Trotter JF, Brown RS, Terrault NA; for the Consortium to Study Health Outcomes in HCV Liver Transplant Recipients (CRUSH-C). Hepatitis C genotype infl uences post-liver transplant outcomes. Transplantation 2014 Sep 10 [Epub ahead of print].

568. deSante J, Caplan A, Hippen B, Testa G, Lantos JD. Was Sarah Murnaghan treated justly? Pediatrics 2014;134(1):155–162.

569. Itoh T, Iwahashi S, Kanak MA, Shimoda M, Takita M, Chujo D, Tamura Y, Rahman AM, Chung WY, Onaca N, Coates PT, Dennison AR, Naziruddin B, Levy MF, Matsumoto S. Elevation of high-mobility group box 1 after clinical autologous islet transplantation and its inverse correlation with outcomes. Cell Transplant 2014;23(2):153–165.

570. Kanak MA, Takita M, Itoh T, SoRelle JA, Murali S, Kunnathodi F, Shahbazov R, Lawrence MC, Levy MF, Naziruddin B. Alleviation of instant blood-mediated infl ammatory reaction in autologous conditions

through treatment of human islets with NF-κB inhibitors. Transplanta-tion 2014;98(5):578–584.

571. Kanak MA, Takita M, Kunnathodi F, Lawrence MC, Levy MF, Naziruddin B. Infl ammatory response in islet transplantation. Int J Endocrinol 2014;2014:451035.

572. Kheradmand T, Anthony TL, Harland RC, Testa G, Hart J, Renz J, Te HS, Marino SR. Antibody-mediated rejection in ABO compatible husband to wife living donor liver transplant and review of the literature. Hum Immunol 2014;75(6):578–583.

573. Kim PT, Saracino G, Jennings L, Ramsay M, McKenna GJ, Testa G, Anthony TL, Onaca N, Ruiz RM, Goldstein RM, Levy MF, Klintmalm GB. Ratio of hepatic arterial fl ow to recipient body weight predicts biliary complications after deceased donor liver transplantation. HPB (Oxford) 2014;16(12):1083–1087.

574. Klintmalm GB, Feng S, Lake JR, Vargas HE, Wekerle T, Agnes S, Brown KA, Nashan B, Rostaing L, Meadows-Shropshire S, Agarwal M, Harler MB, Garcia-Valdecasas JC. Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study. Am J Transplant 2014;14(8):1817–1827.

575. Klintmalm GB, Nashan B. Th e role of mTOR inhibitors in liver trans-plantation: reviewing the evidence. J Transplant 2014;2014:845438.

576. Klintmalm GB, Saab S, Hong JC, Nashan B. Th e role of mammalian target of rapamycin inhibitors in the management of post-transplant malignancy. Clin Transplant 2014;28(6):635–648.

577. Kruel CR, Ruiz RM, Shiller SM, Anthony TL, Goldstein RM, Kim PTW, Levy MF, McKenna GJ, Onaca N, Testa G, Klintmalm GB. Posttransplant lymphoproliferative disorder presenting as a small bowel obstruction in a patient with pancreas transplantation alone. Proc (Bayl Univ Med Cent) 2014;27(4):346–348.

578. Lee JJ, Kim PT, Fischer S, Fung S, Gallinger S, McGilvray I, Moulton CA, Wei AC, Greig PD, Cleary SP. Impact of viral hepatitis on outcomes after liver resection for hepatocellular carcinoma: results from a North American center. Ann Surg Oncol 2014;21(8):2708–2716.

579. Levy G, Villamil FG, Nevens F, Metselaar HJ, Clavien PA, Klintmalm G, Jones R, Migliaccio M, Prestele H, Orsenigo R; REFINE Study Group. REFINE: a randomized trial comparing cyclosporine A and tacrolimus on fi brosis after liver transplantation for hepatitis C. Am J Transplant 2014;14(3):635–646.

580. Naziruddin B, Iwahashi S, Kanak MA, Takita M, Itoh T, Levy MF. Evidence for instant blood-mediated infl ammatory reaction in clini-cal autologous islet transplantation. Am J Transplant 2014;14(2):428–437.

581. O’Leary JG, Demetris AJ, Friedman LS, Gebel HM, Halloran PF, Kirk AD, Knechtle SJ, McDiarmid SV, Shaked A, Terasaki PI, Tinckam KJ, Tomlanovich SJ, Wood KJ, Woodle ES, Zachary AA, Klintmalm GB. Th e role of donor-specifi c HLA alloantibodies in liver transplantation. Am J Transplant 2014;14(4):779–787.

582. O’Leary JG, Kaneku H, Demetris AJ, Marr JD, Shiller SM, Susskind BM, Tillery GW, Terasaki PI, Klintmalm GB. Antibody-mediated rejec-tion as a contributor to previously unexplained early liver allograft loss. Liver Transpl 2014;20(2):218–227.

583. O’Leary JG, Kaneku H, Jennings L, Susskind BM, Terasaki PI, Klintmalm GB. Donor-specifi c alloantibodies are associated with fi brosis progression after liver transplantation in hepatitis C virus-infected patients. Liver Transpl 2014;20(6):655–663.

584. O’Leary JG, Shiller SM Bellamy C, Nalesnik MA, Kaneku H, Jennings LW, Isse K, Terasaki PI, Klintmalm GB, Demetris AJ. Acute liver al-lograft antibody-mediated rejection: an inter- institutional study of significant histopathological features. Liver Transpl 2014;20(10):1244–1255.

585. Onaca N, Stone MJ, Fulmer M, Klintmalm G. Transplantation for primary hepatic malignancy. In Busuttil RW, Klintmalm GB, eds. Transplantation of the Liver, 3rd ed. Saunders, 2014.

586. Serrano PE, Cleary SP, Dhani N, Kim PT, Greig PD, Leung K, Moulton CA, Gallinger S, Wei AC. Improved long-term outcomes after resection of pancreatic adenocarcinoma: a comparison between two time periods. Ann Surg Oncol 2014 Oct 28 [Epub ahead of print].


284284

587. Shimoda M, Chen S, Noguchi H, Takita M, Sugimoto K, Itoh T, Chujo D, Iwahashi S, Naziruddin B, Levy MF, Matsumoto S, Grayburn PA. A new method for generating insulin-secreting cells from human pancreatic epithelial cells after islet isolation transformed by NeuroD1. Hum Gene Th er Methods 2014;25(3):206–219.

588. Sugimoto K, Itoh T, Takita M, Shimoda M, Chujo D, SoRelle JA, Naziruddin B, Levy MF, Shimada M, Matsumoto S. Improving alloge-neic islet transplantation by suppressing Th 17 and enhancing Treg with histone deacetylase inhibitors. Transpl Int 2014;27(4):408–415.

589. Takita M, Itoh T, Shimoda M, Kanak MA, Shahbazov R, Kunnathodi F, Lawrence MC, Naziruddin B, Levy MF. Pancreatic ductal perfusion at organ procurement enhances islet yield in human islet isolation. Pancreas 2014;43(8):1249–1255.

590. Temple SJ, Kim PT, Serrano PE, Kagedan D, Cleary SP, Moulton CA, McGilvray ID, Gallinger S, Greig PD, Wei AC. Combined pancreatico-duodenectomy and colon resection for locally advanced peri- ampullary tumours: analysis of peri-operative morbidity and mortality. HPB ( Oxford) 2014;16(9):797–800.

591. Testa G. Ethical issues regarding related and nonrelated living organ donors. World J Surg 2014;38(7):1658–1663.

592. Trotter JF. Challenges in living donor liver transplantation. Clin Liver Dis 2014;18(3):651–660.

593. Trotter JF, Lizardo-Sanchez L. Everolimus in liver transplantation. Curr Opin Organ Transplant 2014;19(6):578–582.

594. Trotter JF, Milliner D. Auxiliary liver transplant is an ineff ective treatment of primary hyperoxaluria. Am J Transplant 2014;14(1):241.

595. Ursales A, Klein JA, Beal SG, Koch M, Clement-Kruzel S, Melton LB, Spak CW. Antibiotic failure in a renal transplant patient with Rhodococcus equi infection: an indication for surgical lobectomy. Transpl Infect Dis 2014;16(6):1019–1023.

596. Yango AF, Fischbach BV, Levy M, Chandrakantan A, Tan V, Spak C, Melton L, Rice K, Barri Y, Rajagopal A, Klintmalm G. West Nile virus infection in kidney and pancreas transplant recipients in the Dallas-Fort Worth Metroplex during the 2012 Texas epidemic. Transplantation 2014;97(9):953–957.

597. Zarghouni M, Cura M, Kim PT, Testa G, Klintmalm GB. Segmental biliary duct N-butyl cyanoacrylate ablation in a transplant liver for a biliary leak after hepaticojejunostomy. Liver Transpl 2014;20(6):739–741.

TRAUMA 598. Bombardier CH, Fann JR, Wilson CS, Heinemann AW, Richards JS,

Warren AM, Brooks L, Warms CA, Temkin NR, Tate DG. A random-ized controlled trial of venlafaxine XR for major depressive disorder after spinal cord injury: methods and lessons learned. J Spinal Cord Med 2014;37(3):247–263.

599. Cook A, Weddle J, Baker S, Hosmer D, Glance L, Friedman L, Osler T. A comparison of the Injury Severity Score and the Trauma Mortality Prediction Model. J Trauma Acute Care Surg 2014;76(1):47–52.

600. Crandall ML, Agarwal S, Muskat P, Ross S, Savage S, Schuster K, Tominaga GT, Shafi S; American Association for the Surgery of Trauma Committee on Patient Assessment and Outcomes. Applica-tion of a uniform anatomic grading system to measure disease severity in eight emergency general surgical illnesses. J Trauma Acute Care Surg 2014;77(5):705–708.

601. Dahdah M, Barnes S, Schmidt K, Buros A, Dubiel R, Dunklin C, Callender L, Shafi S. Th e impact of preexisting illness on patient func-tional outcomes and neuropsychological performance following TBI. Arch Clin Neuropsychol 2014;29(6):583–584.

602. Dahdah MN, Barisa MT, Schmidt K, Barnes SA, Dubiel R, Dunklin C, Harper C, Callender L, Wilson A, Diaz-Arrastia R, Shafi S. Com-parative eff ectiveness of traumatic brain injury rehabilitation: diff erential outcomes across TBI model systems centers. J Head Trauma Rehabil 2014;29(5):451–459.

603. Driver S, Warren AM, Reynolds M, Agtarap S, Hamilton R, Trost Z, Monden K. Identifying predictors of resilience at inpatient and 3-month post-spinal cord injury. J Spinal Cord Med 2014 Oct 9 [Epub ahead of print].

604. Field C, Walters S, Marti CN, Jun J, Foreman M, Brown C. A multisite randomized controlled trial of brief intervention to reduce drinking in the trauma care setting: how brief is brief? Ann Surg 2014;259(5):873–880.

605. Field CA, Cochran G, Caetano R, Foreman M, Brown CV. Postdischarge nonmedical use of prescription opioids in at-risk drinkers admitted to urban level I trauma centers. J Trauma Acute Care Surg 2014;76(3):833–839.

606. Gale SC, Shafi S, Dombrovskiy VY, Arumugam D, Crystal JS. Th e pub-lic health burden of emergency general surgery in the United States: A 10-year analysis of the Nationwide Inpatient Sample—2001 to 2010. J Trauma Acute Care Surg 2014;77(2):202–208.

607. Gandhi RR, Overton TL, Haut ER, Lau B, Vallier HA, Rohs T, Hasenboehler E, Lee JK, Alley D, Watters J, Rogers FB, Shafi S. Optimal timing of femur fracture stabilization in polytrauma patients: A practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg 2014;77(5):787–795.

608. Kelley E, Sullivan C, Loughlin JK, Hutson L, Dahdah MN, Long MK, Schwab KA, Poole JH. Self-awareness and neurobehavioral outcomes, 5 years or more after moderate to severe brain injury. J Head Trauma Rehabil 2014;29(2):147–152.

609. Kline JA, Hernandez J, Garrett JS, Jones AE. Pilot study of a protocol to administer inhaled nitric oxide to treat severe acute submassive pul-monary embolism. Emerg Med J 2014;31(6):459–462.

610. Le D, Shafi S, Gwirtz P, Bennett M, Reeves R, Callender L, Dunklin C, Cleveland S. Eff ect of obesity on motor functional outcome of rehabili-tating traumatic brain injury patients. Am J Phys Med Rehabil 2014 Oct 8 [Epub ahead of print].

611. Monden KR, Trost Z, Catalano D, Garner AN, Symcox J, Driver S, Hamilton RG, Warren AM. Resilience following spinal cord injury: a phenomenological view. Spinal Cord 2014;52(3):197–201.

612. Overton TL, Rives TE, Hecht C, Shafi S, Gandhi RR. Distracted driving: prevalence, problems, and prevention. Int J Inj Contr Saf Promot 2014 Feb 5 [Epub ahead of print].

613. Overton TL, Shafi S, Cravens GF, Gandhi RR. Can trauma surgeons manage mild traumatic brain injuries? Am J Surg 2014;208(5):806–810.

614. Overton TL, Shafi S, Gandhi RR. Local access to care programs increase trauma patient follow-up compliance. Am J Surg 2014;208(3):476–479.

615. Overton TL, Williams G, Shafi S, Gandhi RR. Utilization of pastoral care services for a screening, brief intervention, and referral-to-treatment program at an urban Level I trauma center. J Emerg Nurs 2014 Mar 12 [Epub ahead of print].

616. Powers MB, Warren AM, Rosenfi eld D, Roden-Foreman K, Bennett M, Reynolds MC, Davis ML, Foreman ML, Petrey LB, Smits JA. Predictors of PTSD symptoms in adults admitted to a Level I trauma center: a pro-spective analysis. J Anxiety Disord 2014;28(3):301–309.

617. Rainey EE, Petrey LB, Reynolds M, Agtarap S, Warren AM. Psychological factors predicting outcome after traumatic injury: the role of resilience. Am J Surg 2014;208(4):517–523.

618. Schwarz ES, Wax PM, Kleinschmidt KC, Sharma K, Chung WM, Cantu G, Spargo E, Todd E. Multiple poisonings with sodium azide at a local restaurant. J Emerg Med 2014;46(4):491–494.

619. Shafi S, Aboutanos M, Brown CV, Ciesla D, Cohen MJ, Crandall ML, Inaba K, Miller PR, Mowery NT; American Association for the Surgery of Trauma Committee on Patient Assessment and Outcomes. Measuring anatomic severity of disease in emergency general surgery. J Trauma Acute Care Surg 2014;76(3):884–887.

620. Shafi S, Barnes SA, Millar D, Sobrino J, Kudyakov R, Berryman C, Rayan N, Dubiel R, Coimbra R, Magnotti LJ, Vercruysse G, Scherer LA, Jurkovich GJ, Nirula R. Suboptimal compliance with evidence-based guidelines in patients with traumatic brain injuries. J Neurosurg 2014;120(3):773–777.

621. Shafi S, Barnes SA, Rayan N, Kudyakov R, Foreman M, Cryer HG, Alam HB, Hoff W, Holcomb J. Compliance with recommended care at trauma centers: association with patient outcomes. J Am Coll Surg 2014;219(2):189–198.

622. Warren AM, Foreman ML, Bennett MM, Petrey LB, Reynolds M, Patel S, Roden-Foreman K. Posttraumatic stress disorder following traumatic


285

injury at 6 months: associations with alcohol use and depression. J Trauma Acute Care Surg 2014;76(2):517–522.

623. Warren AM, Stucky K, Sherman JJ. Rehabilitation psychology’s role in the level I trauma center. J Trauma Nurs 2014;21(3):139–145.

624. Williams RT, Wilson CS, Heinemann AW, Lazowski LE, Fann JR, Bombardier CH; PRISMS Investigators. Identifying depression severity risk factors in persons with traumatic spinal cord injury. Rehabil Psychol 2014;59(1):50–56.

HISTORY625. Jones RC. 110 Years of Surgery at Baylor University Medical Center. Dallas,

TX: Baylor Health Care System, 2014.626. Jones RC. Th e president’s been shot and they are bringing him to the

emergency room. J Am Coll Surg 2014;218(4):856–868. 627. Roberts WC. Foreword. In Winters WL Jr, Parish B. Hosuton Hearts: A

History of Cardiovascular Surgery and Medicine and Th e Methodist DeBakey Heart & Vascular Center Houston Methodist Hospital. Houston, TX: Elisha Freeman Publishing, 2014.

628. Stone RH, Stone MJ. Jules Stein: visionary extraordinaire. In Cooper DKC, ed. Doctors of Another Calling: Physicians Who Are Best Known in Fields Other than Medicine. Newark: University of Delaware Press, 2014:295–304.

EDITORIALS AND MISCELLANEOUS629. Abramson A. I wish I had known: residency study advice. Next Steps

Derm 2014 (June 12).630. Dahdah M, Shafi S. Comparative eff ectiveness, covariates, complex

treatment, and complex outcomes: a response to comments by Sherer, Dijkers, Whyte, and Nick on the above topics. J Head Trauma Rehabil 2014;29(5):462–463.

631. Edwards WLJ, Fay JW, Ramsay M, Roberts AD Jr., Stone MJ. Tributes to George J. Race, MD, PhD. Proc (Bayl Univ Med Cent) 2014;27(2):150–152.

632. Emmett E, Fordtran JS, Mennel RG, Miller AM, Pippen JE, Sutker WL. Tributes to Marvin J. Stone, MD, on his retirement. Proc (Bayl Univ Med Cent) 2014;27(1):51–55.

633. Fleshman JW Jr., Roberts WC. James Walter Fleshman Jr., MD: a conver-sation with the editor. Proc (Bayl Univ Med Cent) 2014;27(3):263–275.

634. Goel A. Can curcumin solve depression? Investigating Curcuma longa as an antidepressant. Natural Medicine Journal 2014;6(11):38–41.

635. Guileyardo JM, Roberts WC. Joseph Manuel Guileyardo, MD: a conver-sation with the editor. Proc (Bayl Univ Med Cent) 2014;27(4):369–376.

636. Hasse JM. Challenges in nutrition support. Nutr Clin Pract 2014;29(5):574–575.

637. Hasse JM. Early postoperative tube feeding in liver transplantation. Nutr Clin Pract 2014;29(2):222–228.

638. Hasse JM. Editor’s note. Nutr Clin Pract 2014;29(2):157–158.639. Hasse JM. Editor’s note. Nutr Clin Pract 2014;29(4):419.640. Hasse JM. Enteral feeding tubes and parenteral nutrition (PN). Nutr

Clin Pract 2014;29(3):263.641. Hasse JM. Nutrition for the critically ill. Nutr Clin Pract 2014;29(1):8–9.642. Hasse JM. Obesity rates. Nutr Clin Pract 2014;29(6):717.643. Holmes DR Jr, Mohr F, Hamm CW, Mack MJ. Venn diagrams in cardio-

vascular disease: the Heart Team concept. Eur Heart J 2014;35(2):66–68. 644. Klintmalm GB. Carl Gustav Groth, MD, PhD. Clin Transplant 2014;

28(4):383.645. Kowey PR, Roberts WC. Peter Russell Kowey, MD: a conversation with

the editor. Am J Cardiol 2014;113(11):1917–1932.

646. Mack M. A consumer’s pursuit of health care outcomes: daunting even with a guardian angel! JAMA Intern Med 2014;174(4):496–497.

647. McCullough PA, Roberts WC. Peter Andrew McCullough, MD, MPH: an interview with the editor. Am J Cardiol 2014;114(11):1772–1785.

648. McCullough PA. Calling for targeted trials in cardiorenal syndromes. Am J Kidney Dis 2014;64(1):10–12.

649. Narula J, Roberts WC. Jagat Narula, MD, PhD: A conversation with the editor. Am J Cardiol 2014;113(12):2070–2085.

650. O’Leary JG. Debate—a bridge too far: Nonalcoholic fatty liver disease will not exhaust the donor pool. Liver Transpl 2014;20(Suppl 2):S38–S41.

651. O’Shaughnessy JA. Commentary. Clin Adv Hematol Oncol 2014;12(3 Suppl 7):17–22.

652. Parker TF 3rd, Aronoff GR. Th e medical director in integrated clinical care models. Clin J Am Soc Nephrol 2014 Oct 28 [Epub ahead of print].

653. Phillips SD, Roberts WC. Sabrina Dean Phillips, MD: a conversation with the editor. Proc (Bayl Univ Med Cent) 2014;27(1):56–62.

654. Ramsay MA, Usman M. In response. Anesth Analg 2014;118(2):486–487. 655. Roberts WC. Board certifi cation scams. Am J Cardiol 2014;114(3):494–495. 656. Roberts WC. Facts and ideas from anywhere. Proc (Bayl Univ Med Cent)

2014;27(1):67–72.657. Roberts WC. Facts and ideas from anywhere. Proc (Bayl Univ Med Cent)

2014;27(2):168–178.658. Roberts WC. Facts and ideas from anywhere. Proc (Bayl Univ Med Cent)

2014;27(3):289–296. 659. Roberts WC. Facts and ideas from anywhere. Proc (Bayl Univ Med Cent)

2014;27(4):383–392.660. Roberts WC. Good books in cardiovascular disease appearing in 2013

and early 2014. Am J Cardiol 2014;113:1774–1775.661. Roberts WC. Proceedings of the editorial board meeting of Th e American

Journal of Cardiology on March 30, 2014. Am J Cardiol 2014;114:324–326.662. Roberts WC. Review of Houston Hearts. Proc (Bayl Univ Med Cent)

2014;27(4):381–382.663. Sangeorzan BJ, Brodsky JW, Th ordarson DB. FAI Update 2014. Foot

Ankle Int 2014;35(11):1101.664. Saucier JL. Th e value of certifi cation. Prog Transplant 2014;24(1):7.665. Schussler JM. Invited commentary: Takotsubo cardiomyopathy following

epidural steroid injection: yet another way to break the heart. Proc (Bayl Univ Med Cent) 2014;27(2):122.

666. Testa G, Siegler M. Increasing the supply of kidneys for transplantation by making living donors the preferred source of donor kidneys. Medicine (Baltimore) 2014;93(29):e318.

667. Toiyama Y, Boland CR, Goel A. Response. J Natl Cancer Inst 2014;106(3):djt458.

668. Verrier ED, Mack MJ. Viewpoint: transitions in cardiac surgery and interventional cardiology…team mates or rivals? Heart 2014 Dec 23 [Epub ahead of print].

669. Winter FD Jr. Review of Selected Roberts Papers from Seven Generations. Proc (Bayl Univ Med Cent) 2014;27(2):166–167.

Note: Th is list (fi nalized on February 11, 2015) was based on submissions from medical and allied health staff and on PubMed searches. Although the list is representative of the year’s publications, some articles and book chapters were undoubtedly missed, since not all researchers respond to the request for publications. Staff are encouraged to submit their publications each year. For more information or to submit publications for this list, please contact Cynthia Orticio ([email protected]).


bapr v28 i2 BUMC Merge - Baylorhealth.edu Proceedings... · 267 the logistic European System for...

Documents

Transcript of bapr v28 i2 BUMC Merge - Baylorhealth.edu Proceedings... · 267 the logistic European System for...